<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="mbt270143" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microb Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">Microb Biotechnol</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1751-7915</journal-id><journal-id journal-id-type="publisher-id">MBT2</journal-id><journal-title-group><journal-title>Microbial Biotechnology</journal-title></journal-title-group><issn pub-type="epub">1751-7915</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407413</article-id><article-id pub-id-type="pmc">PMC12101070</article-id><article-id pub-id-type="doi">10.1111/1751-7915.70143</article-id><article-id pub-id-type="publisher-id">MBT270143</article-id><article-id pub-id-type="other">MICROBIO-2024-599-RAR.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>
<italic toggle="no">Toxoplasma gondii</italic>
<styled-content style="fixed-case" toggle="no">C2</styled-content> Domain Protein Deletion Mutant as a Promising Vaccine Against Toxoplasmosis in Mice</article-title></title-group><contrib-group><contrib id="mbt270143-cr-0001" contrib-type="author"><name><surname>Luo</surname><given-names>Yifan</given-names></name><xref rid="mbt270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mbt270143-cr-0002" contrib-type="author"><name><surname>He</surname><given-names>Mingfeng</given-names></name><xref rid="mbt270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mbt270143-cr-0003" contrib-type="author"><name><surname>Yang</surname><given-names>Shengqiang</given-names></name><xref rid="mbt270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mbt270143-cr-0004" contrib-type="author"><name><surname>Qian</surname><given-names>Jiahui</given-names></name><xref rid="mbt270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mbt270143-cr-0005" contrib-type="author"><name><surname>He</surname><given-names>Zhengming</given-names></name><xref rid="mbt270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mbt270143-cr-0006" contrib-type="author"><name><surname>Xu</surname><given-names>Jiayin</given-names></name><xref rid="mbt270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mbt270143-cr-0007" contrib-type="author"><name><surname>Guo</surname><given-names>Liyu</given-names></name><xref rid="mbt270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mbt270143-cr-0008" contrib-type="author" corresp="yes"><name><surname>Xiao</surname><given-names>Siyu</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0006-8239-6994</contrib-id><xref rid="mbt270143-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>siyux@mail.hzau.edu.cn</email></address></contrib><contrib id="mbt270143-cr-0009" contrib-type="author" corresp="yes"><name><surname>Fang</surname><given-names>Rui</given-names></name><xref rid="mbt270143-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>fangrui@mail.hzau.edu.cn</email></address></contrib></contrib-group><aff id="mbt270143-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine</named-content>
<institution>Huazhong Agricultural University</institution>
<city>Wuhan</city>
<named-content content-type="country-part">Hubei</named-content>
<country country="CN">China</country>
</aff><aff id="mbt270143-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">College of Veterinary Medicine</named-content>
<institution>Huazhong Agricultural University</institution>
<city>Wuhan</city>
<named-content content-type="country-part">Hubei</named-content>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Siyu Xiao (<email>siyux@mail.hzau.edu.cn</email>)<break/>
Rui Fang (<email>fangrui@mail.hzau.edu.cn</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2025</year></pub-date><volume>18</volume><issue seq="180">5</issue><issue-id pub-id-type="doi">10.1111/mbt2.v18.5</issue-id><elocation-id>e70143</elocation-id><history>
<date date-type="rev-recd"><day>03</day><month>3</month><year>2025</year></date>
<date date-type="received"><day>28</day><month>10</month><year>2024</year></date>
<date date-type="accepted"><day>29</day><month>3</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Microbial Biotechnology</italic> published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:MBT2-18-e70143.pdf"/><abstract><title>ABSTRACT</title><p>
<italic toggle="no">Toxoplasma gondii</italic> (<italic toggle="no">T. gondii</italic>), a parasitic protozoan capable of infecting nearly all warm&#x02010;blooded animals, causes significant economic losses in livestock and poses a significant threat to both animal and public health. Despite its impact, no ideal vaccine is currently available to prevent toxoplasmosis. Vesicular transport plays a crucial role in the life cycle of <italic toggle="no">T.&#x02009;gondii</italic>, and proteins involved in this process &#x02013; such as those containing C2 domains &#x02013; may serve as novel targets for the development of live attenuated vaccines. In this study, we evaluated the feasibility of a C2 domain&#x02010;containing protein (TGME49_203240) as a live attenuated vaccine candidate. Our findings suggest that TGME49_203240 may be involved in vesicular transport and that it is essential for <italic toggle="no">T.&#x02009;gondii</italic> growth. Deletion of TGME49_203240 reduced parasite virulence and impaired tissue cyst formation in mice. Moreover, mice vaccinated with ME49<italic toggle="no">&#x00394;203240</italic> were protected against the lethal challenge of the tachyzoites of <italic toggle="no">T.&#x02009;gondii</italic> I, II, III strains and cysts of II strain. In addition, the ME49<italic toggle="no">&#x00394;203240</italic> strain elicited robust immune responses, including the production of high levels of specific IgG antibodies and key cytokines (IFN&#x02010;&#x003b3;, TNF&#x02010;&#x003b1; and IL&#x02010;12). These findings highlight TGME49_203240 as a promising target for the development of a live attenuated vaccine against <italic toggle="no">T.&#x02009;gondii</italic>.</p></abstract><abstract abstract-type="graphical"><p>Without TGME49_203240, a C2 domain&#x02010;containing protein, the virulence of <italic toggle="no">T.&#x02009;gondii</italic> is much weakened. Immunisation of mice with the ME49&#x00394;203240 strain produces a Th1&#x02010;biased immune response against reinfection by the <italic toggle="no">T.&#x02009;gondii</italic> I, II and III strains.<boxed-text position="anchor" content-type="graphic" id="mbt270143-blkfxd-0001"><graphic xlink:href="MBT2-18-e70143-g003.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="mbt270143-kwd-0001">C2 domain</kwd><kwd id="mbt270143-kwd-0002">immune protection</kwd><kwd id="mbt270143-kwd-0003">live attenuated vaccine</kwd><kwd id="mbt270143-kwd-0004">TGME49_203240</kwd><kwd id="mbt270143-kwd-0005"><italic toggle="no">Toxoplasma gondii</italic></kwd><kwd id="mbt270143-kwd-0006">vesicle transport</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Key Research and Development Program of China
</institution><institution-id institution-id-type="doi">10.13039/501100012166</institution-id></institution-wrap></funding-source><award-id>2022YFD1800200</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="1"/><page-count count="17"/><word-count count="9300"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:23.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="mbt270143-ntgp-0001"><fn fn-type="funding" id="mbt270143-note-0001"><p>
<bold>Funding:</bold> This study was supported by National Key Research and Development Program of China, 2022YFD1800200.</p></fn></fn-group></notes></front><body id="mbt270143-body-0001"><sec id="mbt270143-sec-0001"><label>1</label><title>Introduction</title><p>
<italic toggle="yes">Toxoplasma gondii</italic> is a highly specialised intracellular parasite that causes zoonotic infections in nearly all warm&#x02010;blooded animals and has a widespread global prevalence (Rostami et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0031" ref-type="bibr">2020</xref>). Its life cycle is notably complex, with sexual reproduction occurring exclusively in felines, the definitive hosts, while asexual replication takes place in intermediate hosts. Toxoplasmosis can be a life&#x02010;threatening disease, particularly for immunocompromised individuals, such as those with AIDS or cancers. If primary infection occurs during pregnancy, it can lead to miscarriage, stillbirth, congenital toxoplasmosis, fetal deformities and other severe complications (Nayeri et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0028" ref-type="bibr">2020</xref>; Almeria and Dubey&#x000a0;<xref rid="mbt270143-bib-0003" ref-type="bibr">2021</xref>). Beyond its impact on human health, toxoplasmosis also causes substantial economic losses in livestock industries, particularly in small ruminants and swine production, leading to abortions, reduced animal product quality and significant zoonotic risks (Foroutan et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0017" ref-type="bibr">2019</xref>; Nayeri et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0029" ref-type="bibr">2021</xref>; Su et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0037" ref-type="bibr">2022</xref>). The development of a <italic toggle="yes">T. gondii</italic> vaccine remains a global challenge. Currently, only one commercial vaccine (Toxovax) is produced by attenuating T. <italic toggle="yes">gondii</italic> through multiple passages after isolating it from lambs. However, Toxovax is only approved for use in sheep, with a high risk of reversion to its virulence (Buxton and Innes&#x000a0;<xref rid="mbt270143-bib-0006" ref-type="bibr">1995</xref>). Therefore, there is an urgent need to develop safe and effective vaccines as well as therapeutic strategies for the prevention, control and treatment of <italic toggle="yes">Toxoplasma</italic> infections.</p><p>Currently, multiple <italic toggle="yes">T. gondii</italic> vaccine candidates have been developed. However, inactivated vaccines have proven ineffective in eliciting robust immunoprotection in animals (Stanley et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0036" ref-type="bibr">2004</xref>; Saavedra et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0032" ref-type="bibr">2004</xref>). While subunit vaccines and DNA vaccines have demonstrated only partial immunoprotection, live attenuated vaccines have exhibited the strongest immunoprotective efficacy. As a result, live attenuated vaccines are considered the most promising strategy for <italic toggle="yes">T. gondii</italic> vaccine development (Bhopale&#x000a0;<xref rid="mbt270143-bib-0004" ref-type="bibr">2003</xref>; Dunay et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0014" ref-type="bibr">2018</xref>; Onile et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0030" ref-type="bibr">2020</xref>; Chu and Quan&#x000a0;<xref rid="mbt270143-bib-0011" ref-type="bibr">2021</xref>). With the advancement in gene editing technologies, the development of genetically modified live attenuated vaccines has become a major research focus. Techniques such as CRISPR/Cas9 and Cre&#x02010;loxp have enabled the precise deletion of virulence&#x02010;related genes, paving the way for safer and more effective vaccine strains. Several gene&#x02010;deletion&#x02010;based live vaccine strains, including <italic toggle="yes">&#x00394;ADSL</italic>, <italic toggle="yes">&#x00394;&#x003b1;&#x02010;AMY</italic> and <italic toggle="yes">&#x00394;OMPDC&#x00394;UP</italic>, have been developed. However, their safety and long&#x02010;term efficacy still require further validation (Fox and Bzik&#x000a0;<xref rid="mbt270143-bib-0018" ref-type="bibr">2010</xref>, <xref rid="mbt270143-bib-0019" ref-type="bibr">2015</xref>; Wang et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0043" ref-type="bibr">2020</xref>; Lyu et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0026" ref-type="bibr">2021</xref>).</p><p>In the field of live attenuated vaccines, most vaccines have been designed by targeting genes associated with parasite adhesion, invasion, replication and biosynthetic pathways of parasites (Fereig and Nishikawa&#x000a0;<xref rid="mbt270143-bib-0016" ref-type="bibr">2016</xref>; Chu and Quan&#x000a0;<xref rid="mbt270143-bib-0011" ref-type="bibr">2021</xref>). For example, microneme protein (MIC) is a class of proteins released by <italic toggle="yes">T. gondii</italic> during cell invasion. Low&#x02010;virulence RH strains with MIC1 and MIC3 genes knockout have been shown to protect mice against <italic toggle="yes">T. gondii</italic> cysts challenge (Cerede et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0008" ref-type="bibr">2005</xref>). Another promising approach involves disrupting the de novo uracil synthesis pathway. Deletion of two enzymes critical &#x02013; the uridine phosphorylase (UP) and orotidine&#x02010;5&#x02032;&#x02010;monophosphate decarboxylase (OMPDC) &#x02013; renders <italic toggle="yes">T. gondii</italic> incapable of growth in standard environments, requiring high concentrations of uracil to persist. Mice immunised with either the UP or OMPDC deficient strains exhibited resistance to the challenge of <italic toggle="yes">T. gondii</italic> type I strain (Fox and Bzik&#x000a0;<xref rid="mbt270143-bib-0018" ref-type="bibr">2010</xref>, <xref rid="mbt270143-bib-0019" ref-type="bibr">2015</xref>; Wilson et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0044" ref-type="bibr">2012</xref>). Similarly, Adenylosuccinate lyase (ADSL), an enzyme involved in the adenylate synthesis pathway, has been identified as a potential target for attenuation. Mice immunised with ADSL&#x02010;deficient <italic toggle="yes">T. gondii</italic> strains developed high levels of specific antibodies, leading to a significant reduction in tissue cyst formation (Wang et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0043" ref-type="bibr">2020</xref>).</p><p>Vesicular transport plays a crucial role in various biological processes and disrupting this pathway can significantly impact the growth and virulence of <italic toggle="yes">T. gondii</italic>. Therefore, proteins involved in vesicular transport may serve as potential antiparasitic targets. Proteins containing the C2 domain were speculated to be involved in the process of vesicular transport, as the C2 domain can bind a variety of substances, including phospholipids, inositol polyphosphates and other substances involved in membrane translocation and signal transduction (Cho and Stahelin&#x000a0;<xref rid="mbt270143-bib-0010" ref-type="bibr">2006</xref>; Zhang and Aravind&#x000a0;<xref rid="mbt270143-bib-0050" ref-type="bibr">2010</xref>; Larsen and Sansom&#x000a0;<xref rid="mbt270143-bib-0025" ref-type="bibr">2021</xref>; Jahn et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0024" ref-type="bibr">2024</xref>). Given their functional significance, the C2 protein family may serve as a potential target for the development of live attenuated <italic toggle="yes">T. gondii</italic> vaccines.</p><p>In this study, we identified TGME49_203240, a C2 domain&#x02010;containing protein that partially co&#x02010;localised with the endoplasmic reticulum. Deletion of the TGME49_203240 gene significantly impacted the growth and virulence of <italic toggle="yes">T. gondii</italic>. We further evaluated the potential of the TGME49_203240 gene knockout strain (ME49<italic toggle="yes">&#x00394;203240</italic>) as a live attenuated vaccine and found that ME49<italic toggle="yes">&#x00394;203240</italic> provided potent immunoprotection against tachyzoite challenge from <italic toggle="yes">T. gondii</italic> types I, II and III, as well as cyst challenge from the type II strain in mice. Moreover, ME49<italic toggle="yes">&#x00394;203240</italic> induced a robust humoral immune response and a Th1&#x02010;biased cellular immune response. These findings highlight TGME49_203240 as a promising target for developing a live attenuated <italic toggle="yes">T. gondii</italic> vaccine, offering a novel approach to toxoplasmosis prevention.</p></sec><sec id="mbt270143-sec-0002"><label>2</label><title>Experimental Procedures</title><sec id="mbt270143-sec-0003"><label>2.1</label><title>Parasite Strains and Cell Lines</title><p>RH<italic toggle="yes">&#x00394;ku80</italic>, RH<italic toggle="yes">&#x00394;HXGPRT</italic>, ME49 and VEG were kept in our laboratory. 203240&#x02010;3HA (TGGT1_203240 localised strain), ME49<italic toggle="yes">&#x00394;203240</italic> (TGME49_203240 gene knockout strain) and Comp&#x02010;<italic toggle="yes">Tg</italic>203240 (ME49<italic toggle="yes">&#x00394;203240</italic> complementation strain) strains were constructed in this study and propagated in human foreskin fibroblasts (HFF).</p><p>Human foreskin fibroblasts (HFF) were cultured in a DMEM medium containing 10% fetal bovine serum (FBS, HY, China) and 1% penicillin&#x02013;streptomycin (Beyotime, China) at a ratio of 3:1 for cell passage.</p><p>
<italic toggle="yes">T. gondii</italic> tachyzoites were propagated in HFF cells in a DMEM medium containing 2% FBS and 1% penicillin&#x02013;streptomycin.</p><p>All cells and parasites were cultured at 37&#x000b0;C, 5% CO<sub>2</sub>.</p></sec><sec id="mbt270143-sec-0004"><label>2.2</label><title>Bioinformatics Analysis</title><p>The sequence of TGME49_203240 was obtained from the ToxoDB database and subjected to analysis in the InterPro database. The conserved sequence of the protein structural domain of the C2D_Tricalbin&#x02010;like protein family was downloaded from the NCBI database. The protein sequences were imported into DNASTAR 11 Protean for analysis of antigenic epitopes and hydrophobicity.</p></sec><sec id="mbt270143-sec-0005"><label>2.3</label><title>Construction of TGME49_203240 Gene Knockout Strain and Complementation Strain</title><p>The corresponding gRNAs were designed using the ToxoDB database, and the CRISPR plasmids were constructed by replacing the UPRT target RNA (gRNA) in pSAG1&#x02010;Cas9&#x02010;sgUPRT with the corresponding gRNA by Q5 targeted mutagenesis kit (NEB, USA). Homology templates used for gene replacements (pTGME49_203240::DHFR) were constructed by multi&#x02010;fragment ligation using the ClonExpress II one&#x02010;step cloning kit (Vazyme, Nanjing, China). Briefly, the 5&#x02032; and 3&#x02032; homology arms of the gene were amplified from the genomic DNA of the ME49 strain and cloned into the pUC19 vector along with DHFR. The CRISPR plasmid targeting TGME49_203240 and the homologous templates, which displace TGME49_203240, were cotransfected into fresh ME49 tachyzoites (Shen and Sibley&#x000a0;<xref rid="mbt270143-bib-0034" ref-type="bibr">2014</xref>; Yang et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0049" ref-type="bibr">2017</xref>). The correct positive clone (ME49<italic toggle="yes">&#x00394;203240</italic>) was screened by the pyrimethamine and identified by PCR (Shen and Sibley&#x000a0;<xref rid="mbt270143-bib-0034" ref-type="bibr">2014</xref>; Yang et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0049" ref-type="bibr">2017</xref>). To construct the complementation strain, we replaced TgLDH 1 in pCom&#x02010;LDH 1 (Xia et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0045" ref-type="bibr">2018</xref>) with the CDS sequence of TGME49_203240. Then pTub::TGME49_203240&#x02010;CAT fragment was transfected into ME49<italic toggle="yes">&#x00394;203240</italic>, and the correct complementation strain (Comp&#x02010;<italic toggle="yes">Tg</italic>203240) was identified through the use of a drug (chloramphenicol), a limited dilution method, PCR and IFA. All primer sequences are shown in Table&#x000a0;<xref rid="mbt270143-tbl-0001" ref-type="table">1</xref>. The Western Blot and IFA were performed as described previously (Sugi et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0039" ref-type="bibr">2017</xref>).</p><table-wrap position="float" id="mbt270143-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Primers used in this study.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Primer</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sequence 5&#x02032;&#x02010;3&#x02032;</th><th align="center" valign="bottom" rowspan="1" colspan="1">Use</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">gRNA&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">AACTTGACATCCCCATTTAC</td><td align="center" valign="top" rowspan="1" colspan="1">To construct gene&#x02010;specific CRISPR plasmids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">gRNA&#x02010;203240&#x02010;3HA&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">GCATGACAGGGAACGCCATGGTTTTAGAGCTAGAAATAGC</td><td align="center" valign="top" rowspan="1" colspan="1">To construct the 203240&#x02010;3HA specific CRISPR plasmid</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5H&#x02010;3HA&#x02010;DHFR&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">GGCGCACGCGGCAGAACCTCGTAGCTTCACCCTTCATCCCTCGAGCAGCTCGCTACCCCTACGATGTGCCGGATT</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of homologous templates 5H&#x02010;3HA&#x02010;DHFR&#x02010;3H for203240&#x02010;3HA strain construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3H&#x02010;3HA&#x02010;DHFR&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">CTTTCCTGACCAACAGTCGCCCCCCTCTCTTCCCGCTCCTCTGTGTCGGCCACCGCTTTCTCAACAGGAAAAAGC</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of homologous templates 5H&#x02010;3HA&#x02010;DHFR&#x02010;3H for203240&#x02010;3HA strain construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">203240&#x02010;3HA&#x02010;PCR1&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">GCGAGTGTGACTATGTGGCG</td><td align="center" valign="top" rowspan="1" colspan="1">PCR1 of 203240&#x02010;3HA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">203240&#x02010;3HA&#x02010;PCR1&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">CGTACTATGGCCGGTCGATG</td><td align="center" valign="top" rowspan="1" colspan="1">PCR1 of 203240&#x02010;3HA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">203240&#x02010;3HA&#x02010;PCR2&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">CCGCGAACGATTGGCGATACGTC</td><td align="center" valign="top" rowspan="1" colspan="1">PCR2 of 203240&#x02010;3HA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">203240&#x02010;3HA&#x02010;PCR2&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">GCTCGCACTCACCACACAGC</td><td align="center" valign="top" rowspan="1" colspan="1">PCR2 of 203240&#x02010;3HA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">gRNA&#x02010;ME49<italic toggle="yes">&#x00394;</italic>203240&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">AGACGCCATACCCCGCACAGGTTTTAGAGCTAGAAATAGC</td><td align="center" valign="top" rowspan="1" colspan="1">To construct the ME49<italic toggle="yes">&#x00394;203240</italic> specific CRISPR plasmid</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ME49<italic toggle="yes">&#x00394;203240</italic>&#x02010;5H&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">GTTGTAAAACGACGGCCAGTAATGTTTCTGCGTCCCCTGT</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of 5&#x02032;&#x02010;homology of TGME49_203240 for p203240:: DHFR homologous recombinant plasmid construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ME49<italic toggle="yes">&#x00394;203240</italic>&#x02010;5H&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">GATGTCTTCTGCGCGGGTTGTTTTTAGACAAGAAAGGCCT</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of 5&#x02032;&#x02010;homology of TGME49_203240 for p203240:: DHFR homologous recombinant plasmid construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ME49<italic toggle="yes">&#x00394;203240</italic>&#x02010;3H&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">GCCACAAGTTCAGCGTGTCCGGCTCCTACGGGGTTTCCTC</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of 3&#x02032;&#x02010;homology of TGME49_203240 for p203240:: DHFR homologous recombinant plasmid construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ME49<italic toggle="yes">&#x00394;203240</italic>&#x02010;3H&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">GCTATGACCATGATTACGCCACCGCTCGCACTCACCATAC</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of 3&#x02032;&#x02010;homology of TGME49_203240 for p203240:: DHFR homologous recombinant plasmid construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PUC19&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">GGCGTAATCATGGTCATAGCTGT</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of pUC19 vector for p203240:: DHFR homologous recombinant plasmid construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PUC19&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">ACTGGCCGTCGTTTTACAACG</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of pUC19 vector for p203240:: DHFR homologous recombinant plasmid construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DHFR&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">CAACCCGCGCAGAAGACATC</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of DHFR for p203240:: DHFR homologous recombinant plasmid construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DHFR&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">GGACACGCTGAACTTGTGGC</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of DHFR for p203240:: DHFR homologous recombinant plasmid construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ME49<italic toggle="yes">&#x00394;203240</italic>&#x02010;PCR1&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">GTTCTCTCGCGAGGCACTTT</td><td align="center" valign="top" rowspan="1" colspan="1">PCR1 of ME49<italic toggle="yes">&#x00394;203240</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ME49<italic toggle="yes">&#x00394;203240</italic>&#x02010;PCR1&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">GATTTGTGAGGACGACTCAC</td><td align="center" valign="top" rowspan="1" colspan="1">PCR1 of ME49<italic toggle="yes">&#x00394;203240</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ME49<italic toggle="yes">&#x00394;203240</italic>&#x02010;PCR2&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">CACGACAGCAGACAACTTTC</td><td align="center" valign="top" rowspan="1" colspan="1">PCR2 of ME49<italic toggle="yes">&#x00394;203240</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ME49<italic toggle="yes">&#x00394;203240</italic>&#x02010;PCR2&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">CACTTGCGGTTCTTGTGACC</td><td align="center" valign="top" rowspan="1" colspan="1">PCR2 of ME49<italic toggle="yes">&#x00394;203240</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ME49<italic toggle="yes">&#x00394;203240</italic>&#x02010;PCR3&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">GTCGGTGAACTCTCTTGTGC</td><td align="center" valign="top" rowspan="1" colspan="1">PCR3 of ME49<italic toggle="yes">&#x00394;203240</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ME49<italic toggle="yes">&#x00394;203240</italic>&#x02010;PCR3&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">TCAGGGGAGGAAGATAAGCC</td><td align="center" valign="top" rowspan="1" colspan="1">PCR3 of ME49<italic toggle="yes">&#x00394;203240</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">gRNA&#x02010;Comp&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">CCTCGCCGAAGTAAGTTCTGGTTTTAGAGCTAGAAATAGC</td><td align="center" valign="top" rowspan="1" colspan="1">To construct gene specific CRISPR plasmids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Comp&#x02010;<italic toggle="yes">Tg</italic>203240&#x02010;PCR4&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">CGGTTGGTGATCCTGGTTGGAC</td><td align="center" valign="top" rowspan="1" colspan="1">PCR4 of Comp&#x02010;<italic toggle="yes">Tg</italic>203240</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Comp&#x02010;<italic toggle="yes">Tg</italic>203240&#x02010;PCR4&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">CTGAGACCTGCGGTGCAGAAG</td><td align="center" valign="top" rowspan="1" colspan="1">PCR4 of Comp&#x02010;<italic toggle="yes">Tg</italic>203240</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Comp&#x02010;<italic toggle="yes">Tg</italic>203240&#x02010;PCR5&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">GCATGTTCGGTTGTACATCG</td><td align="center" valign="top" rowspan="1" colspan="1">PCR5 of Comp&#x02010;<italic toggle="yes">Tg</italic>203240</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Comp&#x02010;<italic toggle="yes">Tg</italic>203240&#x02010;PCR5&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">GCGAATACACATAGTCACACCG</td><td align="center" valign="top" rowspan="1" colspan="1">PCR5 of Comp&#x02010;<italic toggle="yes">Tg</italic>203240</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TGME49_203240&#x02010;CDS&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">CTTACGATGTTCCAGATTATGCCGCACCTGCTGCTCCGAACAAG</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of TGME49_203240&#x02010;CDS::HA for pTub::TGME49_203240::HA::CAT construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TGME49_203240&#x02010;CDS&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">GCAGCTTCTGTGGGCTGCATAGCTGCTCGAGGGATGAAGGGTGAAG</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of TGME49_203240&#x02010;CDS::HA for pTub:: TGME49_203240::HA::CAT construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Comp&#x02010;TGME49_203240&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">CATGATTACGCCAAGCTCGG</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of TGME49_203240&#x02010;CDS::HA for pTub:: TGME49_203240::HA::CAT construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Comp&#x02010;TGME49_203240&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">AAACGACGGCCAGTGAATTG</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of TGME49_203240&#x02010;CDS::HA for pTub:: TGME49_203240::HA::CAT construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">pET32a&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">GTCGACAAGCTTGCGGCCGCACTCG</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of pET32a vector for all the <styled-content style="fixed-case" toggle="no">
<italic toggle="no">E. coli</italic>
</styled-content> transfection plasmid construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">pET32a&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">ATGATGATGATGATGGTGCATATGGCC</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of pET32a vector for all the <styled-content style="fixed-case" toggle="no">
<italic toggle="no">E. coli</italic>
</styled-content> transfection plasmid construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TGME49_203240&#x02010;CDS&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">CTTACGATGTTCCAGATTATGCCGCACCTGCTGCTCCGAACAAG</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of TGME49_203240&#x02010;CDS for pET32a&#x02010;TGME49_203240 construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TGME49_203240&#x02010;CDS&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">GCAGCTTCTGTGGGCTGCATAGCTGCTCGAGGGATGAAGGGTGAAG</td><td align="center" valign="top" rowspan="1" colspan="1">Amplification of TGME49_203240&#x02010;CDS for pET32a&#x02010;TGME49_203240 construction</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">pET32a&#x02010;TGME49_203240&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">ATGCACCATCATCATCATCATGCACCTGCTGCTCCGAACAA</td><td align="center" valign="top" rowspan="1" colspan="1">Construction of pET32a&#x02010;TGME49_203240 plasmid for <styled-content style="fixed-case" toggle="no">
<italic toggle="no">E. coli</italic>
</styled-content> protein expression</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">pET32a&#x02010;TGME49_203240&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">GCGGCCGCAAGCTTGTCGACAGAGTAGCCCTGGGGCAGGA</td><td align="center" valign="top" rowspan="1" colspan="1">Construction of pET32a&#x02010;TGME49_203240 plasmid for <styled-content style="fixed-case" toggle="no">
<italic toggle="no">E. coli</italic>
</styled-content> protein expression</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RT&#x02010;tubulin&#x02010;F</td><td align="center" valign="top" rowspan="1" colspan="1">CACTGGTACACGGGTGAAGGT</td><td align="center" valign="top" rowspan="1" colspan="1">For qPCR detection in parasite burden assay</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RT&#x02010;tubulin&#x02010;R</td><td align="center" valign="top" rowspan="1" colspan="1">ATTCTCCCTCTTCCTCTGCG</td><td align="center" valign="top" rowspan="1" colspan="1">For qPCR detection in parasite burden assay</td></tr></tbody></table></table-wrap></sec><sec id="mbt270143-sec-0006"><label>2.4</label><title>Localisation Assay of TGME49_203240</title><p>The 203240&#x02010;3HA strain was constructed by transfecting the targeting CRISPR plasmid and a homologous template with a 3HA&#x02010;DHFR tag into fresh RH&#x00394;<italic toggle="yes">ku80</italic> tachyzoites by CRISPR/Cas9 gene editing. It was also characterised by screening with 1&#x02009;&#x003bc;M pyrimethamine, PCR and IFA.</p><p>Fresh tachyzoites of the 203240&#x02010;3HA strain were transferred to glass slides full of HFF cells for overnight growth and then fixed with 4% paraformaldehyde at room temperature, permeabilised with 0.1% Triton X&#x02010;100, closed in 10% FBS (diluted with PBS) at 37&#x000b0;C and stained with mouse&#x02010;anti&#x02010;HA, mouse&#x02010;anti&#x02010;GRASP, mouse&#x02010;anti&#x02010;GAP50, mouse&#x02010;anti&#x02010;MIC&#x02010;2, rabbit&#x02010;anti&#x02010;<italic toggle="yes">Tg</italic>ALD, rabbit&#x02010;anti&#x02010;<italic toggle="yes">Tg</italic>SERCA, rabbit&#x02010;anti&#x02010;GRA7, rabbit&#x02010;anti&#x02010;ROP17 and rabbit&#x02010;anti <italic toggle="yes">Tg</italic>GAP45 as primary antibodies. Alexa&#x02010;488&#x02010;R, Alexa&#x02010;596&#x02010;M and Hoechst were used as secondary antibodies for staining, and after adding an anti&#x02010;fluorescence quencher, the staining was observed under a fluorescence microscope.</p></sec><sec id="mbt270143-sec-0007"><label>2.5</label><title>Preparation of Polyclonal Antibodies to TGME49_203240</title><p>The CDS sequence of TGME49_203240 was amplified from the cDNA of the ME49 strain. Following this, it was ligated with the pET32a vector to construct the pET32a&#x02010;203240 prokaryotic expression plasmid. Protein expression was then carried out with <styled-content style="fixed-case" toggle="no">
<italic toggle="no">E. coli</italic>
</styled-content> BL21(DE3) engineering bacteria. Once the bacterial culture had reached the logarithmic growth phase (as indicated by an OD600 reading of 0.5&#x02013;0.6), the protein expression process was initiated by the addition of IPTG (1&#x02009;mM) and continued for 4&#x02009;h at 37&#x000b0;C. Following the disruption of the bacterial fluid, inclusion body proteins were isolated, denatured and purified using a nickel column. Finally, the purified proteins were identified through SDS&#x02010;PAGE analysis.</p><p>The purified proteins were combined with the Fourier adjuvant in a 1:1 ratio and subsequently administered to mice via subcutaneous injection at separate points. Each mouse received 75&#x02009;&#x003bc;g of protein. The initial immunisation was conducted with complete F&#x02010;adjuvant, while all subsequent immunisations were performed with incomplete F&#x02010;adjuvant. Following the fourth immunisation, serum was collected. The binding capacity of the antigen and polyclonal antibody was evaluated through Western blot analysis. (All the results are in the Supplementary chart Figure&#x000a0;<xref rid="mbt270143-supitem-0001" ref-type="supplementary-material">S1</xref>).</p></sec><sec id="mbt270143-sec-0008"><label>2.6</label><title>Plaque Assay</title><p>The fresh tachyzoites of <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic> were inoculated into 6&#x02010;well plates full of HFF cells (200 <italic toggle="yes">Tg</italic>/per well) and cultured for 10&#x02009;days at 37&#x000b0;C in a 5% CO<sub>2</sub> incubator. After the medium was washed away with PBS, the infected HFF cells were fixed with 4% paraformaldehyde at room temperature, stained with 0.1% crystalline violet at 37&#x000b0;C, dried and the pictures were scanned with a scanner.</p></sec><sec id="mbt270143-sec-0009"><label>2.7</label><title>Invasive Capability Assay</title><p>Purified tachyzoites were inoculated onto glass slides pre&#x02010;seeded with HFF cells (10^6 <italic toggle="yes">Tg</italic>/well) and incubated at 37&#x000b0;C for 15&#x02009;min. After washing three times with PBS, the cells were fixed with 4% paraformaldehyde at room temperature for 7&#x02009;min. Subsequently, the slides were incubated with mouse anti&#x02010;<italic toggle="yes">T. gondii</italic> IgG antibody (1:100 dilution) at 37&#x000b0;C for 30&#x02009;min, followed by permeabilisation with 0.1% Triton X&#x02010;100 for 20&#x02009;min at 37&#x000b0;C and blocking nonspecific binding with 10% FBS (diluted in PBS) at 37&#x000b0;C for 20&#x02009;min. Next, the slides were incubated with rabbit anti&#x02010;<italic toggle="yes">Tg</italic>ALD antibody at 37&#x000b0;C for 30&#x02009;min, followed by staining with Alexa&#x02010;488&#x02010;R, Alexa&#x02010;596&#x02010;M and Hoechst for 20&#x02009;min. The number of invasive and non&#x02010;invasive <italic toggle="yes">T. gondii</italic> tachyzoites and host cell nuclei were quantified under a fluorescence microscope. A total of 15&#x02013;20 fields of view were analysed, with at least 200 tachyzoites counted per experiment. The invasion rate was calculated as follows: (number of invaded <italic toggle="yes">T. gondii</italic>&#x02014;number of uninvaded <italic toggle="yes">T. gondii</italic>) / total number of nuclei.</p></sec><sec id="mbt270143-sec-0010"><label>2.8</label><title>Replication Assay</title><p>Freshly purified <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic> tachyzoites were inoculated into the glass slides full of HFF cells at 37&#x000b0;C for 1&#x02009;h. Uninvaded <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic> tachyzoites were washed away with PBS, and incubation was continued at 37&#x000b0;C for 24&#x02009;h. Then, the cells were treated as above. The number of parasites per parasitophorous vacuole (PV) was calculated, and at least 200 PVs were counted in each group.</p></sec><sec id="mbt270143-sec-0011"><label>2.9</label><title>Parasite Burden Assay</title><p>Seven&#x02010;week&#x02010;old female ICR mice were injected intraperitoneally with 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup> ME49<italic toggle="yes">&#x00394;203240</italic> or wild&#x02010;type ME49 tachyzoites, respectively, in 5 mice per group. After 5&#x02009;days of infection, the mice were euthanised, and the peritoneal fluids were collected and centrifuged. Then, the gDNA was extracted by taking 1/20 of the mixed ascites for the detection of the parasite&#x02010;loaded volume using qPCR.</p></sec><sec id="mbt270143-sec-0012"><label>2.10</label><title>Detection of <italic toggle="no">T. gondii</italic> Virulence and Tissue Cyst&#x02010;Forming Ability</title><p>Purified fresh <italic toggle="yes">T. gondii</italic> tachyzoites were counted and diluted with FBS&#x02010;free DMEM medium. For the virulence experiments, each mouse was injected with 200 ME49<italic toggle="yes">&#x00394;203240</italic> tachyzoites, and the control was injected with the same number of wild&#x02010;type ME49 strains. Brain tissues of mice were collected after infected parasites for 30&#x02009;days, and the number of tissue cysts was detected by DBA&#x02010;FITC.</p><p>For the gradient virulence experiments, each mouse was injected with 10<sup>2</sup>, 10<sup>3</sup>, 10<sup>4</sup> and 10<sup>5</sup> ME49<italic toggle="yes">&#x00394;203240</italic> strains, and the control group was injected with 200 tachyzoites of wild&#x02010;type ME49 strains.</p></sec><sec id="mbt270143-sec-0013"><label>2.11</label><title>
<styled-content style="fixed-case" toggle="no">HE</styled-content> Staining of the Liver, Spleen and Lung</title><p>After mice were immunised with 200 ME49<italic toggle="yes">&#x00394;203240</italic> and ME49 tachyzoites for 30&#x02009;days, the liver, lungs, spleen and liver were taken and fixed in 4% paraformaldehyde at room temperature for 24&#x02009;h (3 mice per group), dehydrated with ethanol, cleared with xylene, embedded in wax and sliced with a slicer. The unimmunised mice were used as controls. Sections were then stained with haematoxylin and eosin (H&#x00026;E).</p></sec><sec id="mbt270143-sec-0014"><label>2.12</label><title>Immunoprotection Against Acute <italic toggle="no">T. gondii</italic> and Chronic Infection</title><p>Female ICR mice were immunised with 200 tachyzoites of ME49 <italic toggle="yes">&#x00394;203240</italic> strains through intraperitoneal injection at 30&#x02010; or 75&#x02010;day post&#x02010;immunisation. Then, the immunised mice were challenged with 10<sup>4</sup> tachyzoites of RH<italic toggle="yes">&#x00394;HXGPRT</italic>, ME49, or VEG, by intraperitoneal injection (10 mice for each group), or 50 fresh cysts of ME49 by oral administration. The survival curves of the mice were observed, recorded and statistically analysed for 30&#x02009;days.</p></sec><sec id="mbt270143-sec-0015"><label>2.13</label><title>Detection of Serum <italic toggle="no">T. gondii</italic>&#x02010;Specific Antibodies and Cytokines by <styled-content style="fixed-case" toggle="no">ELISA</styled-content>
</title><p>Sera from mice immunised with the 200 ME49<italic toggle="yes">&#x00394;203240</italic> strain for 30, 75 and 125&#x02009;days were collected. The TSA of <italic toggle="yes">T. gondii</italic> is prepared as in this description (Yang et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0048" ref-type="bibr">2020</xref>). The 96&#x02010;well plates were coated overnight with TSA at a concentration of 16&#x02009;&#x003bc;g/mL. After blocking, mouse serum (diluted 1:100) was added and incubated at 37&#x000b0;C for 45&#x02009;min. Subsequently, the plates were incubated with goat anti&#x02010;mouse IgG&#x02010;HRP, goat anti&#x02010;mouse IgG2a and goat anti&#x02010;mouse IgG1 for 30&#x02009;min. Colour development was initiated by adding TMB substrate for 5&#x02009;min, followed by the addition of a stop solution. The OD630 was measured using a microplate reader.</p><p>Cytokines were detected by the Elisa Max Deluxe Set Mouse kit (Biolegend, USA) for IL&#x02010;4, IL&#x02010;12, IFN&#x02010;&#x003b3; and TNF&#x02010;&#x003b1;.</p></sec><sec id="mbt270143-sec-0016"><label>2.14</label><title>Statistical Analysis</title><p>Statistical analyses were performed in Prism 10 software (GraphPad Software Inc., La Jolla, CA, USA) with unpaired <italic toggle="yes">t</italic>&#x02010;test, two&#x02010;way ANOVA test, Mantel&#x02010;Cox log&#x02010;rank test, <italic toggle="yes">p</italic>&#x02009;&#x0003e;&#x02009;0.05 for ns (not significant differences), <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 for * (statistical difference), <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 for ** (statistically significant difference) and <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001 for *** (extremely statistically significant difference).</p></sec></sec><sec sec-type="results" id="mbt270143-sec-0017"><label>3</label><title>Results</title><sec id="mbt270143-sec-0018"><label>3.1</label><title>Bioinformatics Analysis</title><p>Using the ToxoDB database and InterPro database, we identified TGME49_203240, a protein containing C2 domains which may be involved in vesicle transport in <italic toggle="yes">T. gondii</italic>. It has a C2 domain at the N&#x02010;terminal (amino acids 100&#x02013;249) and three transmembrane structural domains at the C&#x02010;terminal end (Figure&#x000a0;<xref rid="mbt270143-fig-0001" ref-type="fig">1A</xref>). However, not all C2 domains are functionally active; some serve merely as structural scaffolds or remain nonfunctional (Cho and Stahelin&#x000a0;<xref rid="mbt270143-bib-0010" ref-type="bibr">2006</xref>; Zhang and Aravind&#x000a0;<xref rid="mbt270143-bib-0050" ref-type="bibr">2010</xref>; Corbalan&#x02010;Garcia and Gomez&#x02010;Fernandez&#x000a0;<xref rid="mbt270143-bib-0013" ref-type="bibr">2014</xref>; Larsen and Sansom&#x000a0;<xref rid="mbt270143-bib-0025" ref-type="bibr">2021</xref>). To further investigate TGME49_203240, we conducted a sequence comparison of its C2 domain using the NCBI database. Our results revealed that the sequence of the TGME49_203240 C2 domain protein exhibits a high degree of similarity to the sequence of the C2 domain protein family of C2D_Tricalbin&#x02010;like proteins which are involved in membrane transport and sorting, suggesting that the C2 domains of TGME49_203240 may be functionally active (Figure&#x000a0;<xref rid="mbt270143-fig-0001" ref-type="fig">1B</xref>) (Essen et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0015" ref-type="bibr">1996</xref>; Xu et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0046" ref-type="bibr">1998</xref>; Verdaguer et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0042" ref-type="bibr">1999</xref>). Based on these findings, we hypothesise that TGME49_203240 may be involved in the process of vesicle transport in <italic toggle="yes">T. gondii</italic>.</p><fig position="float" fig-type="FIGURE" id="mbt270143-fig-0001"><label>FIGURE 1</label><caption><p>Bioinformatics analysis of TGME49_203240. (A) Schematic structure of TGME49_203240. Data from InterPro. (B) Comparison of the structural domain of the C2 domain of TGME49_203240 with conserved sequences of the C2D_Tricalbin&#x02010;like family. Putative Ca<sup>2+</sup> ion&#x02010;binding sites are labelled with the &#x02018;#&#x02019; under the sequence.</p></caption><graphic xlink:href="MBT2-18-e70143-g002" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="mbt270143-sec-0019"><label>3.2</label><title>TGME49_203240 Is Partially Co&#x02010;Localised With <italic toggle="no">T. gondii</italic> Endoplasmic Reticulum</title><p>To further explore whether TGME49_203240 is involved in the vesicular transport process of <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic>, its subcellular localisation needs to be determined. Thus, the 203240&#x02010;3HA strain was constructed, and the PCR identification confirmed its successful generation (Figure&#x000a0;<xref rid="mbt270143-fig-0002" ref-type="fig">2A,B</xref>). Subsequently, the subcellular localisation of TGME49_203240 was determined by indirect immunofluorescence (IFA) (Figure&#x000a0;<xref rid="mbt270143-fig-0002" ref-type="fig">2C&#x02013;E</xref>). The results showed that the HA tag was partially co&#x02010;localised with cytoplasmic protein (<italic toggle="yes">Tg</italic>ALD) and endoplasmic reticulum (<italic toggle="yes">Tg</italic>SERCA). However, it does not colocalise with gliding&#x02010;associated protein (<italic toggle="yes">Tg</italic>GAP45). These findings suggest that TGME49_203240 primarily functions in the endoplasmic reticulum and cytoplasm of <italic toggle="yes">T. gondii</italic>. Additionally, a murine polyclonal antibody against TGME49_203240 was generated to examine potential differences in localisation across different <italic toggle="yes">T. gondii</italic> strains. The results indicated that TGME49_203240 localisation remains consistent between RH and ME49 strains (Figure&#x000a0;<xref rid="mbt270143-supitem-0001" ref-type="supplementary-material">S2</xref>).</p><fig position="float" fig-type="FIGURE" id="mbt270143-fig-0002"><label>FIGURE 2</label><caption><p>Localisation assay of TGME49_203240. (A) Schematic diagram of 203240&#x02010;3HA strain construction. The 3HA&#x02010;DHFR tag was integrated into the TGGT1_203240 gene of RH<italic toggle="yes">&#x00394;ku80</italic> strain by CRISPR/Cas9 gene editing system. (B) PCR identification of 203240&#x02010;3HA strain. PCR1 and PCR2 represent the correct position of the 3HA&#x02010;DHFR insertion into the RH<italic toggle="yes">&#x00394;ku80</italic> strain. (C&#x02013;E) IFA to determine TGME49_203240 subcellular localisation. Scale bar&#x02009;=&#x02009;2&#x02009;&#x003bc;m. (C) Immunofluorescence analysis of the transgenic parasites with mouse anti&#x02010;HA and rabbit anti&#x02010;<italic toggle="yes">Tg</italic>ALD antibodies. (D) Immunofluorescence analysis of the transgenic parasites with mouse anti&#x02010;HA and rabbit anti&#x02010;<italic toggle="yes">Tg</italic>SERCA antibodies. (E) Immunofluorescence analysis of the transgenic parasites with mouse anti&#x02010;HA and rabbit anti&#x02010;<italic toggle="yes">Tg</italic>GAP45 antibodies.</p></caption><graphic xlink:href="MBT2-18-e70143-g004" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="mbt270143-sec-0020"><label>3.3</label><title>TGME49_203240 Is Important for <italic toggle="no">T. gondii</italic> Growth In&#x000a0;Vitro</title><p>To investigate the role of TGME49_203240 in <italic toggle="yes">T. gondii</italic>, a knockout strain (ME49<italic toggle="yes">&#x00394;203240</italic>) was generated using CRISPR/Cas9 gene&#x02010;editing technology (Figure&#x000a0;<xref rid="mbt270143-fig-0003" ref-type="fig">3A</xref>). Following pyrimethamine selection, the correct mutant strain was identified by PCR analysis (Figure&#x000a0;<xref rid="mbt270143-fig-0003" ref-type="fig">3B</xref>). Western blot analysis further confirmed the successful deletion of TGME49_203240 at the protein level (Figure&#x000a0;<xref rid="mbt270143-fig-0003" ref-type="fig">3C</xref>).</p><fig position="float" fig-type="FIGURE" id="mbt270143-fig-0003"><label>FIGURE 3</label><caption><p>Deletion of TGME49_203240 and effects on growth of <italic toggle="yes">T. gondii</italic> in&#x000a0;vitro. (A) Schematic diagram of TGME49_203240 gene deletion strain construction. (B) PCR identification of ME49<italic toggle="yes">&#x00394;203240</italic> strain with deletion of TGME49_203240. PCR1 and PCR2 represent the successful insertion of the DHFR tag into the correct gene position, and PCR3 represents the successful deletion of the TGME49_203240 gene. (C) Western Blot identification of ME49<italic toggle="yes">&#x00394;203240</italic> strain with deletion of TGME49_203240. Mouse&#x02010;anti&#x02010;TGME49_203240 and rabbit&#x02010;anti&#x02010;<italic toggle="yes">Tg</italic>ALD as primary antibodies. (D) Plaque assay of ME49<italic toggle="yes">&#x00394;203240</italic> and ME49 strain. (E) Plaque number of ME49 and ME49<italic toggle="yes">&#x00394;203240</italic> strain, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, unpaired <italic toggle="yes">t</italic>&#x02010;test. (F) Plaque area of ME49 and ME49<italic toggle="yes">&#x00394;203240</italic> strain, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, unpaired <italic toggle="yes">t</italic>&#x02010;test. (G and H) In&#x000a0;vitro growth assay of strain ME49 and ME49<italic toggle="yes">&#x00394;203240</italic> strain with mouse&#x02010;anti&#x02010;<italic toggle="yes">T. gondii</italic> and rabbit&#x02010;anti&#x02010;<italic toggle="yes">Tg</italic>ALD. (G) Invasion assay of ME49 and ME49<italic toggle="yes">&#x00394;203240</italic> strain, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, two&#x02010;way ANOVA. (H) Replication assay of ME49<italic toggle="yes">&#x00394;203240</italic> and ME49 strain, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, two&#x02010;way ANOVA.</p></caption><graphic xlink:href="MBT2-18-e70143-g005" position="anchor" id="jats-graphic-7"/></fig><p>To assess the impact of TGME49_203240 gene deletion on the growth of <italic toggle="yes">Toxoplasma</italic> tachyzoites in&#x000a0;vitro, the phenotype assays of ME49<italic toggle="yes">&#x00394;203240</italic> were performed. Plaque assay showed that the size and number of plaques formed by strain ME49<italic toggle="yes">&#x00394;203240</italic> were significantly different from those formed by wild&#x02010;type strain ME49, with plaques formed by strain ME49<italic toggle="yes">&#x00394;203240</italic> being smaller than those formed by wild&#x02010;type strain ME49, and with fewer plaques formed by strain ME49<italic toggle="yes">&#x00394;203240</italic> (Figure&#x000a0;<xref rid="mbt270143-fig-0003" ref-type="fig">3D&#x02013;F</xref>). Additionally, the results of the invasion capability assay showed that the deletion of the TGME49_203240 gene significantly reduced the invasion ability of the ME49<italic toggle="yes">&#x00394;203240</italic> strain compared with the ME49 strain (Figure&#x000a0;<xref rid="mbt270143-fig-0003" ref-type="fig">3G</xref>). Besides, the replication assay demonstrated that the ME49<italic toggle="yes">&#x00394;203240</italic> strain exhibited significantly slower replication in&#x000a0;vitro compared to the wild&#x02010;type ME49 strain. Collectively, these results demonstrated that TGME49_203240 gene deletion significantly impairs the in&#x000a0;vitro growth of <italic toggle="yes">Toxoplasma</italic> tachyzoites (Figure&#x000a0;<xref rid="mbt270143-fig-0003" ref-type="fig">3H</xref>).</p><p>Furthermore, we aimed to investigate whether the deletion of TGME49_203240 affects the localisation of several organelle markers involved in <italic toggle="yes">T. gondii</italic> vesicle transport. Notably, the deletion of TGME49_203240 did not significantly alter the localisation of cytoplasmic, Golgi, rhoptry, microneme, dense granule, or gliding&#x02010;associated proteins (Figure&#x000a0;<xref rid="mbt270143-supitem-0001" ref-type="supplementary-material">S3</xref>).</p></sec><sec id="mbt270143-sec-0021"><label>3.4</label><title>TGME49_203240 Gene Deletion Affects the Proliferation Rate of <italic toggle="no">T. gondii</italic> in Mice</title><p>To evaluate whether the deletion of the TGME49_203240 gene impacts the replication and proliferation rate of tachyzoites in&#x000a0;vivo, fluorescence qPCR was used to quantify the relative content of tachyzoites in the peritoneal fluid of mice. The results showed that the proliferation rate of the ME49<italic toggle="yes">&#x00394;203240</italic> strain was reduced significantly in mice compared with the wild type (Figure&#x000a0;<xref rid="mbt270143-fig-0004" ref-type="fig">4A</xref>). These findings suggest that TGME49_203240 gene deletion leads to a significant reduction in the replication and proliferation rate of tachyzoites in&#x000a0;vivo.</p><fig position="float" fig-type="FIGURE" id="mbt270143-fig-0004"><label>FIGURE 4</label><caption><p>TGME49_203240 deletion results in reduced parasite virulence and reduced tissue cyst formation. (A) Parasite load experiment of ME49 and ME49<italic toggle="yes">&#x00394;203240</italic> in mouse. 7&#x02010;week&#x02010;old female ICR mice were injected with 10<sup>4</sup> ME49 or ME49<italic toggle="yes">&#x00394;203240</italic> strain, and parasite burdens in the peritoneal fluid of mice were detected after infecting 5&#x02009;days by qPCR, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, unpaired <italic toggle="yes">t</italic>&#x02010;test. (B) Virulence test, 7&#x02010;week&#x02010;old ICR mice, 10 in each group, were infected with 200 ME49 or ME49<italic toggle="yes">&#x00394;203240</italic> strain, mantel Cox log&#x02010;rank test analysis, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01. (C) Gradient virulence test, 7&#x02010;week&#x02010;old ICR mice, 10 in each group, were infected with 10<sup>2</sup> ME49 and 10<sup>2</sup>, 10<sup>3</sup>, 10<sup>4</sup>, 10<sup>5</sup> ME49<italic toggle="yes">&#x00394;203240</italic> strain, mantel Cox log&#x02010;rank test analysis, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01. (D) Brain cyst loads. The surviving mice in (B) were sacrificed, and the number of brain cysts were stained with DBA&#x02010;FITC and counted under a fluorescence microscope, *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, unpaired <italic toggle="yes">t</italic>&#x02010;test. (E) DBA staining of brain cysts. Tissue cysts stained with DBA&#x02010;FITC and imaged on fluorescence microscopy. Scale bar&#x02009;=&#x02009;5&#x02009;&#x003bc;m. (F) HE stained liver, lung and spleen sections from mice injected with ME49<italic toggle="yes">&#x00394;203240</italic> and ME49 strains after 30&#x02009;days. Arrows represent pathological changes. In mice infected with the ME49 strain, the arrows in the histopathological sections of the liver represent foci of mixed cell infiltration (macrophages and neutrophils), the arrows in the lungs represent a large perivascular mixed cell infiltration (macrophages and neutrophils), and the arrows in the spleen represent a severe reduction in the number of lymphocytes within the splenic white and red marrow.</p></caption><graphic xlink:href="MBT2-18-e70143-g007" position="anchor" id="jats-graphic-9"/></fig></sec><sec id="mbt270143-sec-0022"><label>3.5</label><title>TGME49_203240 Deletion Results in Reduced Parasite Virulence and Reduced Tissue Cyst Formation</title><p>Virulence experiments and gradient virulence experiments were conducted to investigate whether the deletion of the TGME49_203240 gene affects the virulence of <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic>. In the virulence experiment, the 30&#x02010;day survival curves of mice are shown in Figure&#x000a0;<xref rid="mbt270143-fig-0004" ref-type="fig">4B</xref>, and the survival rate of mice injected with the ME49<italic toggle="yes">&#x00394;203240</italic> strain was 100%, whereas the mortality rate of mice injected with the wild&#x02010;type ME49 strain was 70%. The result suggests that the deletion of the TGME49_203240 gene reduces the virulence of parasites. Subsequently, to further confirm the extent of reduced virulence of <italic toggle="yes">Toxoplasma</italic> after deletion of the TGME49_203240 gene, the gradient virulence assay was performed, and mice were injected intraperitoneally with 10<sup>2</sup>, 10<sup>3</sup>, 10<sup>4</sup> and 10<sup>5</sup> ME49<italic toggle="yes">&#x00394;203240</italic> strains, while the controls were injected with 200 ME49 strains. As shown in Figure&#x000a0;<xref rid="mbt270143-fig-0004" ref-type="fig">4C</xref>, inoculation with 10<sup>4</sup> and 10<sup>5</sup> ME49<italic toggle="yes">&#x00394; 203240</italic> strains resulted in the death of all mice within 30&#x02009;days, with a survival rate of 30% in the 10<sup>3</sup> group, 80% in the 10<sup>2</sup> group and 10% in the mice inoculated with wild&#x02010;type ME49 strains, suggesting that the deletion of the TGME49_203240 gene reduced the virulence of <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic> to a certain degree, but the ME49<italic toggle="yes">&#x00394;203240</italic> strain remained highly virulent at high doses.</p><p>In addition, the ability to form brain cysts of the ME49<italic toggle="yes">&#x00394;203240</italic> strain was evaluated. After being injected with 200 tachyzoites of the ME49<italic toggle="yes">&#x00394;203240</italic> strain for 30&#x02009;days, live mice were euthanised, and their brain tissues were collected for counting. The results are shown in Figure&#x000a0;<xref rid="mbt270143-fig-0004" ref-type="fig">4D,E</xref>. Compared with mice injected with the ME49 strain, those mice injected with the ME49<italic toggle="yes">&#x00394;203240</italic> strain had a significantly lower number of brain cysts (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05). This indicates that deletion of the TGME49_203240 gene significantly reduces the ability of <italic toggle="yes">T. gondii</italic> to form brain cysts.</p><p>To further evaluate the safety of the ME49<italic toggle="yes">&#x00394;203240</italic> strain, lung, spleen and liver tissues were collected from mice injected with 200 ME49<italic toggle="yes">&#x00394;203240</italic> and ME49 tachyzoites after 30&#x02009;days and examined for tissue damage by HE staining. Histopathological analysis revealed almost no significant changes in the tissue sections of mice immunised with ME49<italic toggle="yes">&#x00394;203240</italic> strain compared to the uninfected mice (Figure&#x000a0;<xref rid="mbt270143-fig-0004" ref-type="fig">4F</xref>). In contrast, mice infected with wild&#x02010;type ME49 exhibited marked inflammation in the liver and lungs, characterised by macrophage and neutrophil infiltration. Lung tissue displayed alveolar wall thickening and structural damage, while the spleen showed a severe reduction in lymphocytes in both the white and red pulp.</p></sec><sec id="mbt270143-sec-0023"><label>3.6</label><title>The Complement of TGME49_203240 Restores <italic toggle="no">T. gondii</italic> In&#x000a0;Vitro Growth Defects and In&#x000a0;Vivo Virulence</title><p>To verify that the reduced virulence and growth defects observed in ME49<italic toggle="yes">&#x00394;203240</italic> strain were indeed due to the deletion of the TGME49_203240 gene, a complement strain (Comp&#x02010;<italic toggle="yes">Tg</italic>203240) was constructed by inserting the CDS fragment of TGME49_203240 into the HXGPRT locus of the ME49<italic toggle="yes">&#x00394;203240</italic> strain (Figure&#x000a0;<xref rid="mbt270143-fig-0005" ref-type="fig">5A</xref>). Following the selection with chloramphenicol, PCR analysis confirmed the correct insertion of the TGME49_203240 CDS fragment (Figure&#x000a0;<xref rid="mbt270143-fig-0005" ref-type="fig">5B</xref>). IFA further verified the successful construction of the Comp&#x02010;Tg203240 strain by detecting the expression of the HA&#x02010;tagged protein (Figure&#x000a0;<xref rid="mbt270143-fig-0005" ref-type="fig">5C</xref>). Additionally, Western blot analysis demonstrated the presence of TGME49_203240 in the Comp&#x02010;Tg203240 strain, while no expression was detected in ME49&#x00394;203240, confirming the successful restoration of TGME49_203240 expression (Figure&#x000a0;<xref rid="mbt270143-fig-0005" ref-type="fig">5D</xref>).</p><fig position="float" fig-type="FIGURE" id="mbt270143-fig-0005"><label>FIGURE 5</label><caption><p>The complement of TGME49_203240 restores <italic toggle="yes">T. gondii</italic> in&#x000a0;vitro growth defects and in&#x000a0;vivo virulence. (A) Schematic diagram of Comp&#x02010;<italic toggle="yes">Tg</italic>203240 strain construction. (B) PCR identification of Comp&#x02010;<italic toggle="yes">Tg</italic>203240 strain. PCR4 represents the successful insertion of the TGME49_203240 CDS sequence, and PCR5 represents the disruption of the HXGPRT site. (C) IFA identification of Comp&#x02010;<italic toggle="yes">Tg</italic>203240 complementation strain. Scale bar&#x02009;=&#x02009;2&#x02009;&#x003bc;m. (D) Western Blot identification of Comp&#x02010;<italic toggle="yes">Tg</italic>203240 strain with complement of TGME49_203240. Primary antibodies were selected from mouse&#x02010;anti&#x02010;TGME49_203240 and rabbit&#x02010;anti&#x02010;<italic toggle="yes">Tg</italic>ALD. (E&#x02013;I) ME49, ME49<italic toggle="yes">&#x00394;203240</italic> and Comp&#x02010;<italic toggle="yes">Tg</italic>203240 phenotyping experiments. (E) Plaque assay, 200 parasites infected HFF cells, grown for 10&#x02009;days and stained with crystal violet. (F) Plaque area, unpaired <italic toggle="yes">t</italic>&#x02010;test, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01. (G) Plaque number, unpaired <italic toggle="yes">t</italic>&#x02010;test, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01. (H) Invasive capability assay, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, two&#x02010;way ANOVA. (I) Replication assay, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, two&#x02010;way ANOVA. (J) Virulence test, seven&#x02010;week&#x02010;old ICR mice, 10 in each group, were infected with 200 ME49, ME49<italic toggle="yes">&#x00394;203240</italic> and Comp&#x02010;<italic toggle="yes">Tg</italic>203240 strain, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, ns, not significant, mantel Cox log&#x02010;rank test analysis.</p></caption><graphic xlink:href="MBT2-18-e70143-g008" position="anchor" id="jats-graphic-11"/></fig><p>Plaque assay results demonstrated that the Comp&#x02010;<italic toggle="yes">Tg</italic>203240 strain formed larger plaques compared to the ME49<italic toggle="yes">&#x00394;203240</italic> strain (Figure&#x000a0;<xref rid="mbt270143-fig-0005" ref-type="fig">5E</xref>), with a statistically significant difference in plaque area and numbers between the two strains (Figure&#x000a0;<xref rid="mbt270143-fig-0005" ref-type="fig">5F,G</xref>). Furthermore, the results of the invasive capability and replication assay showed that the phenotypic defects of the ME49<italic toggle="yes">&#x00394;203240</italic> strain were somewhat restored after complement with TGME49_203240 CDS (Figure&#x000a0;<xref rid="mbt270143-fig-0005" ref-type="fig">5H,I</xref>). These results further verified that TGME49_203240 is important for the in&#x000a0;vitro growth of <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic>.</p><p>The virulence experiments showed that the survival rate of mice infected with the wild&#x02010;type ME49 strain was 40%, mice infected with the Comp&#x02010;<italic toggle="yes">Tg</italic>203240 strain had a 50% survival rate while mice infected with the ME49<italic toggle="yes">&#x00394;203240</italic> strain had a 100% survival rate (Figure&#x000a0;<xref rid="mbt270143-fig-0005" ref-type="fig">5J</xref>). These results suggest that the complementation of TGME49_203240 significantly enhances virulence, highlighting the critical role of TGME49_203240 in <italic toggle="yes">T. gondii</italic> virulence.</p></sec><sec id="mbt270143-sec-0024"><label>3.7</label><title>
<styled-content style="fixed-case" toggle="no">ME49<italic toggle="no">&#x00394;203240</italic>
</styled-content> Vaccination Provides Robust Immune Protection in Mice</title><p>The deletion of the TGME49_203240 gene significantly reduced the virulence of <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic> and its proliferative ability in mice, which made us speculate that the ME49<italic toggle="yes">&#x00394;203240</italic> strain may be a potential live attenuated vaccine against <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic>. To evaluate whether the ME49<italic toggle="yes">&#x00394;203240</italic> strain could provide immunoprotection in mice, immunoprotection experiments were performed.</p><p>Following a 30&#x02010;day immunisation period with 200 ME49<italic toggle="yes">&#x00394;203240</italic> strains, mice were challenged with 1&#x02009;&#x000d7;&#x02009;10<sup>4</sup>&#x02009;
<italic toggle="yes">T. gondii</italic> tachyzoites of type I strains (RH<italic toggle="yes">&#x00394;HXGPRT</italic>), type II strains (ME49) and type III strains (VEG). The results demonstrated that the survival rate of all mice in the immunised group was 100%, whereas the survival rate of mice in the unimmunised group was 0% (type I), 0% (type II) and 50% (type III), respectively (Figure&#x000a0;<xref rid="mbt270143-fig-0006" ref-type="fig">6A&#x02013;C</xref>). These findings suggest that the ME49<italic toggle="yes">&#x00394;203240</italic> strain provides robust immune protection against the challenge of <italic toggle="yes">T. gondii</italic> I, II and III strains within 30&#x02009;days. Moreover, to determine whether the ME49<italic toggle="yes">&#x00394;203240</italic> strain could provide long&#x02010;term immune protection for mice, the duration of immunisation was extended to 75&#x02009;days in this study. The results demonstrated that the survival rates of mice immunised with 200 ME49<italic toggle="yes">&#x00394;203240</italic> strains for 75&#x02009;days were 90% (type I), 100% (type II) and 100% (type III), whereas the survival rates of mice in the unimmunised group were 0% (type I), 0% (type II) and 60% (type III) (Figure&#x000a0;<xref rid="mbt270143-fig-0006" ref-type="fig">6D&#x02013;F</xref>).</p><fig position="float" fig-type="FIGURE" id="mbt270143-fig-0006"><label>FIGURE 6</label><caption><p>ME49<italic toggle="yes">&#x00394;203240</italic> immunisation protected mice from <italic toggle="yes">T. gondii</italic> tachyzoite and cyst challenge. (A&#x02010;C) Seven&#x02010;week&#x02010;old ICR mice were immunised with ME49<italic toggle="yes">&#x00394;203240</italic> tachyzoites. After 30&#x02009;days post&#x02010;immunisation, the mice were challenged with 10<sup>4</sup> tachyzoites of RH<italic toggle="yes">&#x00394;HXGPRT</italic> (A), ME49 (B), or VEG (C) via intraperitoneal injection and their survival was monitored for another 30&#x02009;days. (D&#x02013;F) Seven&#x02010;week&#x02010;old ICR mice were immunised with ME49<italic toggle="yes">&#x00394;203240</italic> tachyzoites. After 75&#x02009;days post&#x02010;immunisation, the mice were challenged with 10<sup>4</sup> tachyzoites of RH<italic toggle="yes">&#x00394;HXGPRT</italic> (D), ME49 (E) or VEG (F) via intraperitoneal injection, and their survival was monitored for another 30&#x02009;days. Unimmunised mice (<italic toggle="yes">n</italic>&#x02009;=&#x02009;10 mice for each strain) were included as a control. (G) Seven&#x02010;week&#x02010;old ICR mice were immunised with ME49<italic toggle="yes">&#x00394;203240</italic> tachyzoites. After 30&#x02009;days post&#x02010;immunisation, the mice were challenged with 50 cysts of the ME49 strain, and the survival of the mice was monitored for 30&#x02009;days. Unimmunised mice (<italic toggle="yes">n</italic>&#x02009;=&#x02009;10 mice for each strain) were included as a control. Mantel&#x02010;Cox log&#x02010;rank test analysis, *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001.</p></caption><graphic xlink:href="MBT2-18-e70143-g001" position="anchor" id="jats-graphic-13"/></fig><p>Besides, to evaluate whether ME49<italic toggle="yes">&#x00394;203240</italic> vaccination could provide protective immunity against cyst infection, the mice immunised with ME49<italic toggle="yes">&#x00394;203240</italic> were challenged with 50 cysts of ME49. The results showed that the survival rate of mice in the immunised group was 100%, whereas the survival rate of mice in the unimmunised group was 60% (Figure&#x000a0;<xref rid="mbt270143-fig-0006" ref-type="fig">6G</xref>). This indicates that ME49<italic toggle="yes">&#x00394;203240</italic> vaccination effectively induced protective immunity against chronic <italic toggle="yes">Toxoplasma</italic> infection. In summary, these findings further indicated that the ME49<italic toggle="yes">&#x00394;203240</italic> strain confers long&#x02010;term immunoprotection in mice following immunisation.</p></sec><sec id="mbt270143-sec-0025"><label>3.8</label><title>
<styled-content style="fixed-case" toggle="no">ME49<italic toggle="no">&#x00394;203240</italic>
</styled-content> Vaccinated Mice Induced Strong Humoral and Cellular Immune Responses</title><p>To investigate the immunoprotective mechanisms induced by the ME49<italic toggle="yes">&#x00394;203240</italic> strain against <italic toggle="yes">T. gondii</italic> challenge, we analysed specific antibody and cytokine responses in the sera of immunised mice.</p><p>The results showed that the immunised mice produced high levels of IFN&#x02010;&#x003b3;, TNF&#x02010;&#x003b1; and IL&#x02010;12 at 30 and 75&#x02009;days post&#x02010;immunisation. However, after 75 and 125&#x02009;days, IFN&#x02010;&#x003b3;, TNF&#x02010;&#x003b1; and IL&#x02010;12 significantly declined compared to 30&#x02009;days, suggesting that the immune response peaked early around day 30 and gradually waned over time. In contrast, IL&#x02010;4 was significantly elevated after days 75 and 125, indicating a potential activation of anti&#x02010;inflammatory mechanisms and a shift in the immune response over time (Figure&#x000a0;<xref rid="mbt270143-fig-0007" ref-type="fig">7A&#x02013;D</xref>).</p><fig position="float" fig-type="FIGURE" id="mbt270143-fig-0007"><label>FIGURE 7</label><caption><p>ME49<italic toggle="yes">&#x00394;203240</italic> vaccinated mice induced strong humoral and cellular immune responses. (A&#x02013;D) ELISA for detection of serum cytokines in mice, which immunised ME49<italic toggle="yes">&#x00394;203240</italic> strain 30, 75 and 125&#x02009;days. (A) IFN&#x02010;&#x003b3;; (B) TFN&#x02010;&#x003b1;; (C) IL&#x02010;12; (D) IL&#x02010;4, ns = not significant, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, unpaired <italic toggle="yes">t</italic>&#x02010;test. (E and F) ELISA for detection of serum&#x02010;specific antibodies in mice, which immunised ME49<italic toggle="yes">&#x00394;203240</italic> strain 30&#x02009;days, 75&#x02009;days and 125&#x02009;days. (E) IgG; (F) IgG1; (G) IgG2a; (H) IgG2a/IgG1, yellow for unimmunised group, blue for immunised group, ns = not significant, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, unpaired <italic toggle="yes">t</italic>&#x02010;test.</p></caption><graphic xlink:href="MBT2-18-e70143-g006" position="anchor" id="jats-graphic-15"/></fig><p>The results also showed that the level of specific IgG antibodies in mice inoculated with the ME49<italic toggle="yes">&#x00394;203240</italic> strain gradually increased with time, peaking at about 75&#x02009;days and maintaining a high level of IgG at 125&#x02009;days. This suggests that the ME49<italic toggle="yes">&#x00394;203240</italic> strain induced a strong humoral immune response in mice (Figure&#x000a0;<xref rid="mbt270143-fig-0007" ref-type="fig">7E</xref>). To further explore the link between the immune responses immunised in mice by the ME49<italic toggle="yes">&#x00394;203240</italic> strain, we examined the IgG2a and IgG1 antibodies. Based on the results of the IgG2a/IgG1 ratio, we found that after 30&#x02009;days of immunisation of mice with the strain, the IgG2a/IgG1 ratio was much greater than 1 and the negative control, which indicated that the ME49<italic toggle="yes">&#x00394;203240</italic> strain induced a Th1&#x02010;biased immune response in mice; however, the IgG2a/IgG1 ratio gradually decreased at 75 and 125&#x02009;days, which may reflect the body's regulatory adjustment of the Th1/Th2 immune balance over time (Figure&#x000a0;<xref rid="mbt270143-fig-0007" ref-type="fig">7F&#x02013;H</xref>).</p><p>In conclusion, immunisation with the ME49<italic toggle="yes">&#x00394;203240</italic> strain induced a strong humoral immune response along with a Th1&#x02010;biased cellular immune response in mice, which in turn protected mice against the challenge of <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic>.</p></sec></sec><sec sec-type="discussion" id="mbt270143-sec-0026"><label>4</label><title>Discussion</title><p>
<italic toggle="yes">T. gondii</italic> is widespread globally, posing a significant threat to public health and farming. Nevertheless, there is currently no effective vaccine or drug available for the prevention and treatment of <italic toggle="yes">T. gondii</italic> infection (Chu and Quan&#x000a0;<xref rid="mbt270143-bib-0011" ref-type="bibr">2021</xref>). In this study, we explored novel strategies for developing a <italic toggle="yes">T. gondii</italic> vaccine by targeting vesicular transport proteins which may play a critical role in the parasite's growth and virulence. Through database and bioinformatic analysis, we found a protein containing a C2 domain (TGME49_203240) and identified that it was localised in the cytoplasm and endoplasmic reticulum. Additionally, we evaluated the potential of the ME49<italic toggle="yes">&#x00394;203240</italic> strain as a live attenuated vaccine candidate and investigated the immune protection mechanism it provides in mice. Our findings demonstrated that the ME49<italic toggle="yes">&#x00394;203240</italic> strain conferred strong immune protection in mice.</p><p>Bioinformatics analysis suggests that TGME49_203240 may be involved in vesicular transport in <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic>, a process essential for the parasite's life activities and virulence. Numerous proteins were found to be involved in the vesicular transport process of <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic>, including members of the SNARE protein family, <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic> SM proteins, endosomal vesicle plugging complex (HOPS), GTPase (DrpB) and Rab (Rab11a, Rab11b) proteins, <italic toggle="yes">etc</italic>. (Breinich et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0005" ref-type="bibr">2009</xref>; Agop&#x02010;Nersesian et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0002" ref-type="bibr">2010</xref>; Jackson et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0023" ref-type="bibr">2013</xref>; Cao et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0007" ref-type="bibr">2020</xref>; Shu et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0035" ref-type="bibr">2020</xref>; Venugopal et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0041" ref-type="bibr">2020</xref>; Fu et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0020" ref-type="bibr">2023</xref>). Additionally, proteins containing the C2 domain, such as Ferlin family proteins and <italic toggle="yes">Tg</italic>DOC2, have also been implicated in <italic toggle="yes">T. gondii</italic> vesicle translocation (Tagoe et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0040" ref-type="bibr">2021</xref>). It is reported that the C2 domain&#x02010;containing proteins may function as Ca<sup>2+</sup>&#x02010;dependent targeting proteins involved in membrane translocation and signal transduction (Nalefski and Falke&#x000a0;<xref rid="mbt270143-bib-0027" ref-type="bibr">1996</xref>; Corbalan&#x02010;Garcia and Gomez&#x02010;Fernandez&#x000a0;<xref rid="mbt270143-bib-0013" ref-type="bibr">2014</xref>).</p><p>In this study, we identified TGME49_203240, a C2 domain&#x02010;containing protein, through the ToxoDB database. Sequence analysis revealed that TGME49_203240 shares structural similarities with SNARE family proteins involved in vesicle fusion, with one side anchoring to the membrane and the other binding to interaction partners. Further sequence comparison, we found that the C2 domain of TGME49_203240 resembles that of C2D_Tricalbin&#x02010;like proteins and has two Ca<sup>2+</sup> binding sites. We also found that TGME49_203240 is localised in the cytoplasm and endoplasmic reticulum of <italic toggle="yes">T. gondii</italic>, which further suggests that TGME49_203240 may be involved in vesicular transport. However, TGME49_203240 does not colocalise with gliding&#x02010;associated protein (<italic toggle="yes">Tg</italic>GAP45), suggesting that TGME49_203240 may be involved in the transport of substances between the endoplasmic reticulum and other organelles as well as vesicle synthesis of <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic> but not participating in extracellular vesicle transport. Additionally, deletion of TGME49_203240 had no significant effect on the localisation of cytoplasmic, Golgi, rhoptry, microneme, dense granule, or gliding&#x02010;associated proteins, indicating that its function may be distinct from known vesicular transport pathways and additional research may be needed to clarify the function of TGME49_203240 (Figure&#x000a0;<xref rid="mbt270143-supitem-0001" ref-type="supplementary-material">S3</xref>).</p><p>Researches support that some C2 domain&#x02010;containing proteins are essential for <italic toggle="yes">T. gondii</italic> growth. The absence of these proteins impacts <italic toggle="yes">Toxoplasma</italic> biological processes such as adhesion, invasion, proliferation, egress and tissue cyst formation. For example, the deletion of FER1 and FER2 of the Ferlin family of proteins affects protein secretion from <italic toggle="yes">T. gondii</italic> microsomes and rods (Coleman et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0012" ref-type="bibr">2018</xref>; Tagoe et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0040" ref-type="bibr">2021</xref>). Whereas knockdown of <italic toggle="yes">Tg</italic>DOC2, a protein containing a double C2 structural domain, affects the secretion of <italic toggle="yes">Toxoplasma</italic> microsomal proteins. The deletion of the RASP2 protein, a protein containing a C2 domain and a PH domain, affects the invasive ability of <italic toggle="yes">Toxoplasma</italic> tachyzoites and reduces rod&#x02010;shaped body protein secretion (Suarez et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0038" ref-type="bibr">2019</xref>). In our study, we found that TGME49_203240 gene deletion causes a defective phenotype characterised by reduced invasive and replicative capacity of <italic toggle="yes">T. gondii</italic>. Given that <italic toggle="yes">T. gondii</italic> FER1 and FER2 also have the same invasive ability&#x02010;deficient phenotype, we hypothesised that the functional impairment observed in the TGME49_203240 knockout strain may be attributed to its C2 domain, which is to be further investigated in subsequent studies.</p><p>The immunoprotective mechanisms against <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic> are complex, involving both humoral and cellular immunity. As an intracellular parasite, <italic toggle="yes">T. gondii</italic> cannot be effectively controlled by high titers of specific IgG alone, making the cellular immune response crucial for protection (Chu and Quan&#x000a0;<xref rid="mbt270143-bib-0011" ref-type="bibr">2021</xref>; Sana et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0033" ref-type="bibr">2022</xref>). Previous studies have shown that while many subunit vaccines for <italic toggle="yes">T. gondii</italic> elicit strong humoral immune responses, they often fail to provide adequate protection against highly virulent strains. For example, <italic toggle="yes">Toxoplasma</italic> tyrosine hydroxylase (<italic toggle="yes">Tg</italic>TH) provided only partial immunoprotection in mice, while subunit vaccines incorporating GRA2 and GRA5 enhanced the Th1&#x02010;type immune response in mice but only prolonged the survival of mice infected with RH strains of the parasite (Ching et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0009" ref-type="bibr">2016</xref>; Zhang et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0051" ref-type="bibr">2020</xref>). In contrast, live attenuated vaccines have demonstrated superior protective efficacy. For example, mice immunised with the ME49<italic toggle="yes">&#x00394;6gpdh</italic> strain for 30&#x02009;days exhibit a survival rate of 80% and 100% when challenged with <italic toggle="yes">T. gondii</italic> RH<italic toggle="yes">&#x00394;ku80</italic> and ME49 strains, respectively (Guo et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0022" ref-type="bibr">2023</xref>). In this study, mice immunised with the ME49<italic toggle="yes">&#x00394;203240</italic> strain for 30&#x02009;days and subsequently challenged with <italic toggle="yes">T. gondii</italic> tachyzoites of RH<italic toggle="yes">&#x00394;HXGPRT</italic>, ME49 and VEG strains, as well as cysts of the ME49 strain, exhibited a 100% survival. These findings indicate that the ME49<italic toggle="yes">&#x00394;203240</italic> strain induced an immune response similar to that generated by natural <italic toggle="yes">T. gondii</italic> infections and provides robust protection against <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic> challenge.</p><p>Meanwhile, we found that ME49<italic toggle="yes">&#x00394;203240</italic> induced high levels of specific antibody IgG and cytokines such as cytokines IFN&#x02010;&#x003b3; and TNF&#x02010;&#x003b1; compared to live attenuated vaccines such as <italic toggle="yes">&#x00394;&#x003b1;&#x02010;amy</italic>, <italic toggle="yes">&#x00394;ADSL</italic>, <italic toggle="yes">etc</italic>. (Wang et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0043" ref-type="bibr">2020</xref>; Yang et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0048" ref-type="bibr">2020</xref>). This suggests that the mechanism of immune response produced by the ME49<italic toggle="yes">&#x00394;203240</italic> strain immunising the organism may be similar to that of these vaccines. To further characterise the humoral immune response, we examined the IgG antibody subtypes, IgG2a and IgG1, which are generally considered indicators of a Th1&#x02010;type and Th2&#x02010;type immune response, respectively. The IgG2a/IgG1 ratio, a commonly used marker for evaluating vaccine immune response, with a ratio greater than 1, indicating a Th1&#x02010;biased response, which is critical for the clearance of intracellular pathogens (Golkar et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0021" ref-type="bibr">2007</xref>; Xu et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0047" ref-type="bibr">2014</xref>; Abasi et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0001" ref-type="bibr">2019</xref>; Rostami et&#x000a0;al.&#x000a0;<xref rid="mbt270143-bib-0031" ref-type="bibr">2020</xref>). In this study, the IgG2a/IgG1 ratio of mice immunised with the ME49<italic toggle="yes">&#x00394;203240</italic> strain at 30&#x02009;days post&#x02010;immunisation was much greater than 1, indicating that the ME49<italic toggle="yes">&#x00394;203240</italic> strain induced a Th1&#x02010;biased immune response in mice. These findings collectively demonstrated that ME49<italic toggle="yes">&#x00394;203240</italic> is a highly promising attenuated <italic toggle="yes">T</italic>. <italic toggle="yes">gondii</italic> vaccine candidate. However, further evaluation of its immunoprotective efficacy in other host species is necessary, along with rigorous safety assessments. In addition, ME49<italic toggle="yes">&#x00394;203240</italic> remains highly virulent at high doses and, like most live attenuated vaccines, can still form tissue cysts in mice. Therefore, co&#x02010;deletion with other genes could be considered to further reduce the virulence.</p><p>In conclusion, this study demonstrated that the deletion of TGME49_203240 impairs the ability of the <italic toggle="yes">T. gondii strain</italic> ME49 to invade, proliferate and form tissue cysts, resulting in a reduction of its virulence. Additionally, the immunoprotective efficacy and safety of the ME49<italic toggle="yes">&#x00394;203240</italic> strain were evaluated in depth in this study. Our findings revealed that the ME49<italic toggle="yes">&#x00394;203240</italic> strain induces a Th1&#x02010;biased cellular immune response as well as a humoral immune response in mice, providing immunoprotection against challenges with both <italic toggle="yes">T. gondii</italic> tachyzoites and bradyzoites. These results underscore the potential of TGME49_203240 as a promising target for the development of a live attenuated <italic toggle="yes">T. gondii</italic> vaccine. However, further refinement is necessary to ensure the safety and optimise the immunoprotection capabilities of the ME49<italic toggle="yes">&#x00394;203240</italic> strain.</p></sec><sec id="mbt270143-sec-0032"><title>Author Contributions</title><p>
<bold>Yifan Luo:</bold> formal analysis, investigation, writing &#x02013; original draft. <bold>Mingfeng He:</bold> investigation, methodology. <bold>Shengqiang Yang:</bold> investigation, methodology, writing &#x02013; review and editing. <bold>Jiahui Qian:</bold> investigation, methodology, writing &#x02013; review and editing. <bold>Zhengming He:</bold> investigation, methodology. <bold>Jiayin Xu:</bold> investigation, methodology. <bold>Liyu Guo:</bold> investigation, methodology. <bold>Siyu Xiao:</bold> conceptualization, data curation, formal analysis, funding acquisition, project administration, resources, supervision, visualization, writing &#x02013; original draft, writing &#x02013; review and editing. <bold>Rui Fang:</bold> conceptualization, data curation, formal analysis, funding acquisition, project administration, supervision, resources, writing &#x02013; original draft, writing &#x02013; review and editing, visualization.</p></sec><sec id="mbt270143-sec-0028"><title>Ethics Statement</title><p>All 7&#x02010;week&#x02010;old female ICR mice were purchased from Hubei Provincial Laboratory Animal Research Centre, Licence No.: SCXK&#x02010;2020&#x02010;0084. All mice were kept in a standard SPF environment according to the requirements of the Animal Ethics Committee of Huazhong Agricultural University, following the requirements of animal welfare and related ethical requirements (Approval No.: HZAUMO&#x02010;2024&#x02010;0076).</p></sec><sec sec-type="COI-statement" id="mbt270143-sec-0029"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="mbt270143-supitem-0001" position="float" content-type="local-data"><caption><p>
Figure S1.&#x02013;S3.
</p></caption><media xlink:href="MBT2-18-e70143-s001.docx"/></supplementary-material></sec></body><back><ack id="mbt270143-sec-0027"><title>Acknowledgements</title><p>This work was supported by the National Key Research and Development Program of China (2022YFD1800200).</p></ack><sec sec-type="data-availability" id="mbt270143-sec-0031"><title>Data Availability Statement</title><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></sec><ref-list content-type="cited-references" id="mbt270143-bibl-0001"><title>References</title><ref id="mbt270143-bib-0001"><mixed-citation publication-type="journal" id="mbt270143-cit-0001">
<string-name>
<surname>Abasi</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Shahabi</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Golkar</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Khezri</surname>
</string-name>, and <string-name>
<given-names>H. H.</given-names>
<surname>Mohammadzadeh</surname>
</string-name>. <year>2019</year>. &#x0201c;<article-title>Evaluation of Immunogenic Effect of <italic toggle="yes">Toxoplasma gondii</italic> Recombinant SAG&#x02010;1 Antigen With Propranolol as Adjuvant in BALB/c Mice</article-title>.&#x0201d; <source>Advances in Pharmaceutical Bulletin</source>
<volume>9</volume>: <fpage>632</fpage>&#x02013;<lpage>639</lpage>.</mixed-citation></ref><ref id="mbt270143-bib-0002"><mixed-citation publication-type="journal" id="mbt270143-cit-0002">
<string-name>
<surname>Agop&#x02010;Nersesian</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Egarter</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Langsley</surname>
</string-name>, <string-name>
<given-names>B. J.</given-names>
<surname>Foth</surname>
</string-name>, <string-name>
<given-names>D. J. P.</given-names>
<surname>Ferguson</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Meissner</surname>
</string-name>. <year>2010</year>. &#x0201c;<article-title>Biogenesis of the Inner Membrane Complex Is Dependent on Vesicular Transport by the Alveolate Specific GTPase Rab11B</article-title>.&#x0201d; <source>PLoS Pathogens</source>
<volume>6</volume>, no. <issue>7</issue>: <elocation-id>e1001029</elocation-id>.<pub-id pub-id-type="pmid">20686666</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0003"><mixed-citation publication-type="journal" id="mbt270143-cit-0003">
<string-name>
<surname>Almeria</surname>, <given-names>S.</given-names>
</string-name>, and <string-name>
<given-names>J. P.</given-names>
<surname>Dubey</surname>
</string-name>. <year>2021</year>. &#x0201c;<article-title>Foodborne Transmission of <italic toggle="yes">Toxoplasma gondii</italic> Infection in the Last Decade. An Overview</article-title>.&#x0201d; <source>Research in Veterinary Science</source>
<volume>135</volume>: <fpage>371</fpage>&#x02013;<lpage>385</lpage>.<pub-id pub-id-type="pmid">33148402</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0004"><mixed-citation publication-type="journal" id="mbt270143-cit-0004">
<string-name>
<surname>Bhopale</surname>, <given-names>G. M.</given-names>
</string-name>
<year>2003</year>. &#x0201c;<article-title>Development of a Vaccine for Toxoplasmosis: Current Status</article-title>.&#x0201d; <source>Microbes and Infection</source>
<volume>5</volume>: <fpage>457</fpage>&#x02013;<lpage>462</lpage>.<pub-id pub-id-type="pmid">12738002</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0005"><mixed-citation publication-type="journal" id="mbt270143-cit-0005">
<string-name>
<surname>Breinich</surname>, <given-names>M. S.</given-names>
</string-name>, <string-name>
<given-names>D. J.</given-names>
<surname>Ferguson</surname>
</string-name>, <string-name>
<given-names>B. J.</given-names>
<surname>Foth</surname>
</string-name>, et&#x000a0;al. <year>2009</year>. &#x0201c;<article-title>A Dynamin Is Required for the Biogenesis of Secretory Organelles in <italic toggle="yes">Toxoplasma gondii</italic>
</article-title>.&#x0201d; <source>Current Biology</source>
<volume>19</volume>: <fpage>277</fpage>&#x02013;<lpage>286</lpage>.<pub-id pub-id-type="pmid">19217293</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0006"><mixed-citation publication-type="journal" id="mbt270143-cit-0006">
<string-name>
<surname>Buxton</surname>, <given-names>D.</given-names>
</string-name>, and <string-name>
<given-names>E. A.</given-names>
<surname>Innes</surname>
</string-name>. <year>1995</year>. &#x0201c;<article-title>A Commercial Vaccine for Ovine Toxoplasmosis</article-title>.&#x0201d; <source>Parasitology</source>
<volume>110</volume>, no. <issue>Suppl</issue>: <fpage>S11</fpage>&#x02013;<lpage>S16</lpage>.<pub-id pub-id-type="pmid">7784124</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0007"><mixed-citation publication-type="journal" id="mbt270143-cit-0007">
<string-name>
<surname>Cao</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Liang</surname>
</string-name>, et&#x000a0;al. <year>2020</year>. &#x0201c;<article-title>The Sec1/Munc18&#x02010;Like Proteins TgSec1 and TgVps45 Play Pivotal Roles in Assembly of the Pellicle and Sub&#x02010;Pellicle Network in <italic toggle="yes">Toxoplasma gondii</italic>
</article-title>.&#x0201d; <source>Molecular Microbiology</source>
<volume>113</volume>, no. <issue>1</issue>: <fpage>208</fpage>&#x02013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.14411</pub-id>.<pub-id pub-id-type="pmid">31670849</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0008"><mixed-citation publication-type="journal" id="mbt270143-cit-0008">
<string-name>
<surname>Cerede</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<given-names>J. F.</given-names>
<surname>Dubremetz</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Soete</surname>
</string-name>, et&#x000a0;al. <year>2005</year>. &#x0201c;<article-title>Synergistic Role of Micronemal Proteins in <italic toggle="yes">Toxoplasma gondii</italic> Virulence</article-title>.&#x0201d; <source>Journal of Experimental Medicine</source>
<volume>201</volume>: <fpage>453</fpage>&#x02013;<lpage>463</lpage>.<pub-id pub-id-type="pmid">15684324</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0009"><mixed-citation publication-type="journal" id="mbt270143-cit-0009">
<string-name>
<surname>Ching</surname>, <given-names>X. T.</given-names>
</string-name>, <string-name>
<given-names>M. Y.</given-names>
<surname>Fong</surname>
</string-name>, and <string-name>
<given-names>Y. L.</given-names>
<surname>Lau</surname>
</string-name>. <year>2016</year>. &#x0201c;<article-title>Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 Against Acute Toxoplasmosis in BALB/c Mice</article-title>.&#x0201d; <source>Frontiers in Microbiology</source>
<volume>7</volume>: <elocation-id>609</elocation-id>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.00609</pub-id>.<pub-id pub-id-type="pmid">27199938</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0010"><mixed-citation publication-type="journal" id="mbt270143-cit-0010">
<string-name>
<surname>Cho</surname>, <given-names>W.</given-names>
</string-name>, and <string-name>
<given-names>R. V.</given-names>
<surname>Stahelin</surname>
</string-name>. <year>2006</year>. &#x0201c;<article-title>Membrane Binding and Subcellular Targeting of C2 Domains</article-title>.&#x0201d; <source>Biochimica et Biophysica Acta</source>
<volume>1761</volume>: <fpage>838</fpage>&#x02013;<lpage>849</lpage>.<pub-id pub-id-type="pmid">16945584</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0011"><mixed-citation publication-type="journal" id="mbt270143-cit-0011">
<string-name>
<surname>Chu</surname>, <given-names>K. B.</given-names>
</string-name>, and <string-name>
<given-names>F. S.</given-names>
<surname>Quan</surname>
</string-name>. <year>2021</year>. &#x0201c;<article-title>Advances in <italic toggle="yes">Toxoplasma gondii</italic> Vaccines: Current Strategies and Challenges for Vaccine Development</article-title>.&#x0201d; <source>Vaccines (Basel)</source>
<volume>9</volume>, no. <issue>5</issue>: <elocation-id>413</elocation-id>. <pub-id pub-id-type="doi">10.3390/vaccines9050413</pub-id>.<pub-id pub-id-type="pmid">33919060</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0012"><mixed-citation publication-type="journal" id="mbt270143-cit-0012">
<string-name>
<surname>Coleman</surname>, <given-names>B. I.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Saha</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sato</surname>
</string-name>, et&#x000a0;al. <year>2018</year>. &#x0201c;<article-title>A Member of the Ferlin Calcium Sensor Family Is Essential for <italic toggle="yes">Toxoplasma gondii</italic> Rhoptry Secretion</article-title>.&#x0201d; <source>MBio</source>
<volume>9</volume>: <elocation-id>e01510&#x02010;18</elocation-id>.<pub-id pub-id-type="pmid">30279285</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0013"><mixed-citation publication-type="journal" id="mbt270143-cit-0013">
<string-name>
<surname>Corbalan&#x02010;Garcia</surname>, <given-names>S.</given-names>
</string-name>, and <string-name>
<given-names>J. C.</given-names>
<surname>Gomez&#x02010;Fernandez</surname>
</string-name>. <year>2014</year>. &#x0201c;<article-title>Signaling Through C2 Domains: More Than One Lipid Target</article-title>.&#x0201d; <source>Biochimica et Biophysica Acta</source>
<volume>1838</volume>: <fpage>1536</fpage>&#x02013;<lpage>1547</lpage>.<pub-id pub-id-type="pmid">24440424</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0014"><mixed-citation publication-type="journal" id="mbt270143-cit-0014">
<string-name>
<surname>Dunay</surname>, <given-names>I. R.</given-names>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Gajurel</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Dhakal</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Liesenfeld</surname>
</string-name>, and <string-name>
<given-names>J. G.</given-names>
<surname>Montoya</surname>
</string-name>. <year>2018</year>. &#x0201c;<article-title>Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice</article-title>.&#x0201d; <source>Clinical Microbiology Reviews</source>
<volume>31</volume>: <elocation-id>e00057&#x02010;17</elocation-id>.<pub-id pub-id-type="pmid">30209035</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0015"><mixed-citation publication-type="journal" id="mbt270143-cit-0015">
<string-name>
<surname>Essen</surname>, <given-names>L. O.</given-names>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Perisic</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Cheung</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Katan</surname>
</string-name>, and <string-name>
<given-names>R. L.</given-names>
<surname>Williams</surname>
</string-name>. <year>1996</year>. &#x0201c;<article-title>Crystal Structure of a Mammalian Phosphoinositide&#x02010;Specific Phospholipase C Delta</article-title>.&#x0201d; <source>Nature</source>
<volume>380</volume>: <fpage>595</fpage>&#x02013;<lpage>602</lpage>.<pub-id pub-id-type="pmid">8602259</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0016"><mixed-citation publication-type="journal" id="mbt270143-cit-0016">
<string-name>
<surname>Fereig</surname>, <given-names>R. M.</given-names>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Nishikawa</surname>
</string-name>. <year>2016</year>. &#x0201c;<article-title>Towards a Preventive Strategy for Toxoplasmosis: Current Trends, Challenges, and Future Perspectives for Vaccine Development</article-title>.&#x0201d; <source>Methods in Molecular Biology</source>
<volume>1404</volume>: <fpage>153</fpage>&#x02013;<lpage>164</lpage>.<pub-id pub-id-type="pmid">27076296</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0017"><mixed-citation publication-type="journal" id="mbt270143-cit-0017">
<string-name>
<surname>Foroutan</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Fakhri</surname>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Riahi</surname>
</string-name>, et&#x000a0;al. <year>2019</year>. &#x0201c;<article-title>The Global Seroprevalence of <italic toggle="yes">Toxoplasma gondii</italic> in Pigs: A Systematic Review and Meta&#x02010;Analysis</article-title>.&#x0201d; <source>Veterinary Parasitology</source>
<volume>269</volume>: <fpage>42</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetpar.2019.04.012</pub-id>.<pub-id pub-id-type="pmid">31079827</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0018"><mixed-citation publication-type="journal" id="mbt270143-cit-0018">
<string-name>
<surname>Fox</surname>, <given-names>B. A.</given-names>
</string-name>, and <string-name>
<given-names>D. J.</given-names>
<surname>Bzik</surname>
</string-name>. <year>2010</year>. &#x0201c;<article-title>Avirulent Uracil Auxotrophs Based on Disruption of Orotidine&#x02010;5&#x02032;&#x02010;Monophosphate Decarboxylase Elicit Protective Immunity to <italic toggle="yes">Toxoplasma gondii</italic>
</article-title>.&#x0201d; <source>Infection and Immunity</source>
<volume>78</volume>: <fpage>3744</fpage>&#x02013;<lpage>3752</lpage>.<pub-id pub-id-type="pmid">20605980</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0019"><mixed-citation publication-type="journal" id="mbt270143-cit-0019">
<string-name>
<surname>Fox</surname>, <given-names>B. A.</given-names>
</string-name>, and <string-name>
<given-names>D. J.</given-names>
<surname>Bzik</surname>
</string-name>. <year>2015</year>. &#x0201c;<article-title>Nonreplicating, Cyst&#x02010;Defective Type II <italic toggle="yes">Toxoplasma gondii</italic> Vaccine Strains Stimulate Protective Immunity Against Acute and Chronic Infection</article-title>.&#x0201d; <source>Infection and Immunity</source>
<volume>83</volume>: <fpage>2148</fpage>&#x02013;<lpage>2155</lpage>.<pub-id pub-id-type="pmid">25776745</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0020"><mixed-citation publication-type="journal" id="mbt270143-cit-0020">
<string-name>
<surname>Fu</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Zhao</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Cao</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Jia</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>An Unconventional SNARE Complex Mediates Exocytosis at the Plasma Membrane and Vesicular Fusion at the Apical Annuli in Toxoplasma Gondii</article-title>.&#x0201d; <source>PLoS Pathogens</source>
<volume>19</volume>: <elocation-id>e1011288</elocation-id>.<pub-id pub-id-type="pmid">36972314</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0021"><mixed-citation publication-type="journal" id="mbt270143-cit-0021">
<string-name>
<surname>Golkar</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Shokrgozar</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Rafati</surname>
</string-name>, et&#x000a0;al. <year>2007</year>. &#x0201c;<article-title>Evaluation of Protective Effect of Recombinant Dense Granule Antigens GRA2 and GRA6 Formulated in Monophosphoryl Lipid a (MPL) Adjuvant Against <italic toggle="yes">Toxoplasma</italic> Chronic Infection in Mice</article-title>.&#x0201d; <source>Vaccine</source>
<volume>25</volume>, no. <issue>21</issue>: <fpage>4301</fpage>&#x02013;<lpage>4311</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2007.02.057</pub-id>.<pub-id pub-id-type="pmid">17418457</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0022"><mixed-citation publication-type="journal" id="mbt270143-cit-0022">
<string-name>
<surname>Guo</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Guo</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Ji</surname>
</string-name>, et&#x000a0;al. <year>2023</year>. &#x0201c;<article-title>Role of 6&#x02010;Phosphogluconate Dehydrogenase Enzyme 1 in Growth and Virulence of <italic toggle="yes">Toxoplasma Gondii</italic> and Development of Attenuated Live Vaccine</article-title>.&#x0201d; <source>Microbial Biotechnology</source>
<volume>16</volume>: <fpage>1957</fpage>&#x02013;<lpage>1970</lpage>. <pub-id pub-id-type="doi">10.1111/1751-7915.14324</pub-id>.<pub-id pub-id-type="pmid">37556171</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0023"><mixed-citation publication-type="journal" id="mbt270143-cit-0023">
<string-name>
<surname>Jackson</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Clucas</surname>
</string-name>, <string-name>
<given-names>N. J.</given-names>
<surname>Mamczur</surname>
</string-name>, <string-name>
<given-names>D. J.</given-names>
<surname>Ferguson</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Meissner</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>
<italic toggle="yes">Toxoplasma gondii</italic> Syntaxin 6 Is Required for Vesicular Transport Between Endosomal&#x02010;Like Compartments and the Golgi Complex</article-title>.&#x0201d; <source>Traffic</source>
<volume>14</volume>: <fpage>1166</fpage>&#x02013;<lpage>1181</lpage>.<pub-id pub-id-type="pmid">23962112</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0024"><mixed-citation publication-type="journal" id="mbt270143-cit-0024">
<string-name>
<surname>Jahn</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<given-names>D. C.</given-names>
<surname>Cafiso</surname>
</string-name>, and <string-name>
<given-names>L. K.</given-names>
<surname>Tamm</surname>
</string-name>. <year>2024</year>. &#x0201c;<article-title>Mechanisms of SNARE Proteins in Membrane Fusion</article-title>.&#x0201d; <source>Nature Reviews. Molecular Cell Biology</source>
<volume>25</volume>: <fpage>101</fpage>&#x02013;<lpage>118</lpage>.<pub-id pub-id-type="pmid">37848589</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0025"><mixed-citation publication-type="journal" id="mbt270143-cit-0025">
<string-name>
<surname>Larsen</surname>, <given-names>A. H.</given-names>
</string-name>, and <string-name>
<given-names>M. S. P.</given-names>
<surname>Sansom</surname>
</string-name>. <year>2021</year>. &#x0201c;<article-title>Binding of Ca<sup>2+</sup>&#x02212;Independent C2 Domains to Lipid Membranes: A Multi&#x02010;Scale Molecular Dynamics Study</article-title>.&#x0201d; <source>Structure</source>
<volume>29</volume>: <fpage>1200</fpage>&#x02013;<lpage>1213.e2</lpage>.<pub-id pub-id-type="pmid">34081910</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0026"><mixed-citation publication-type="journal" id="mbt270143-cit-0026">
<string-name>
<surname>Lyu</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Yang</surname>
</string-name>, et&#x000a0;al. <year>2021</year>. &#x0201c;<article-title>Role of Amylopectin Synthesis in <italic toggle="yes">Toxoplasma gondii</italic> and Its Implication in Vaccine Development Against Toxoplasmosis</article-title>.&#x0201d; <source>Open Biology</source>
<volume>11</volume>: <elocation-id>200384</elocation-id>.<pub-id pub-id-type="pmid">34129780</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0027"><mixed-citation publication-type="journal" id="mbt270143-cit-0027">
<string-name>
<surname>Nalefski</surname>, <given-names>E. A.</given-names>
</string-name>, and <string-name>
<given-names>J. J.</given-names>
<surname>Falke</surname>
</string-name>. <year>1996</year>. &#x0201c;<article-title>The C2 Domain Calcium&#x02010;Binding Motif: Structural and Functional Diversity</article-title>.&#x0201d; <source>Protein Science</source>
<volume>5</volume>: <fpage>2375</fpage>&#x02013;<lpage>2390</lpage>.<pub-id pub-id-type="pmid">8976547</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0028"><mixed-citation publication-type="journal" id="mbt270143-cit-0028">
<string-name>
<surname>Nayeri</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sarvi</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Moosazadeh</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Amouei</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Hosseininejad</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Daryani</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>The Global Seroprevalence of Anti&#x02010;<italic toggle="yes">Toxoplasma gondii</italic> Antibodies in Women Who Had Spontaneous Abortion: A Systematic Review and Meta&#x02010;Analysis</article-title>.&#x0201d; <source>PLoS Neglected Tropical Diseases</source>
<volume>14</volume>: <elocation-id>e0008103</elocation-id>.<pub-id pub-id-type="pmid">32168351</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0029"><mixed-citation publication-type="journal" id="mbt270143-cit-0029">
<string-name>
<surname>Nayeri</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sarvi</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Moosazadeh</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Daryani</surname>
</string-name>. <year>2021</year>. &#x0201c;<article-title>Global Prevalence of <italic toggle="yes">Toxoplasma gondii</italic> Infection in the Aborted Fetuses and Ruminants That Had an Abortion: A Systematic Review and Meta&#x02010;Analysis</article-title>.&#x0201d; <source>Veterinary Parasitology</source>
<volume>290</volume>: <elocation-id>109370</elocation-id>.<pub-id pub-id-type="pmid">33550003</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0030"><mixed-citation publication-type="journal" id="mbt270143-cit-0030">
<string-name>
<surname>Onile</surname>, <given-names>O. S.</given-names>
</string-name>, <string-name>
<given-names>G. J.</given-names>
<surname>Ojo</surname>
</string-name>, <string-name>
<given-names>B. F.</given-names>
<surname>Oyeyemi</surname>
</string-name>, <string-name>
<given-names>G. O.</given-names>
<surname>Agbowuro</surname>
</string-name>, and <string-name>
<given-names>A. I.</given-names>
<surname>Fadahunsi</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>Development of Multiepitope Subunit Protein Vaccines Against <italic toggle="yes">Toxoplasma gondii</italic> Using an Immunoinformatics Approach</article-title>.&#x0201d; <source>NAR Genomics and Bioinformatics</source>
<volume>2</volume>: <elocation-id>lqaa048</elocation-id>.<pub-id pub-id-type="pmid">33575600</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0031"><mixed-citation publication-type="journal" id="mbt270143-cit-0031">
<string-name>
<surname>Rostami</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Riahi</surname>
</string-name>, <string-name>
<given-names>H. R.</given-names>
<surname>Gamble</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Fakhri</surname>
</string-name>, and <string-name>
<given-names>R. B.</given-names>
<surname>Gasser</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>Global Prevalence of Latent Toxoplasmosis in Pregnant Women: A Systematic Review and Meta&#x02010;Analysis</article-title>.&#x0201d; <source>Clinical Microbiology and Infection</source>
<volume>26</volume>, no. <issue>6</issue>: <fpage>673</fpage>&#x02013;<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmi.2020.01.008</pub-id>.<pub-id pub-id-type="pmid">31972316</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0032"><mixed-citation publication-type="journal" id="mbt270143-cit-0032">
<string-name>
<surname>Saavedra</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Leyva</surname>
</string-name>, <string-name>
<given-names>E. P.</given-names>
<surname>Tenorio</surname>
</string-name>, et&#x000a0;al. <year>2004</year>. &#x0201c;<article-title>CpG&#x02010;Containing ODN has a Limited Role in the Protection Against <italic toggle="yes">Toxoplasma gondii</italic>
</article-title>.&#x0201d; <source>Parasite Immunology</source>
<volume>26</volume>: <fpage>67</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">15225293</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0033"><mixed-citation publication-type="journal" id="mbt270143-cit-0033">
<string-name>
<surname>Sana</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Rashid</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Rashid</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Akbar</surname>
</string-name>, <string-name>
<given-names>J. E.</given-names>
<surname>Gomez&#x02010;Marin</surname>
</string-name>, and <string-name>
<given-names>I.</given-names>
<surname>Dimier&#x02010;Poisson</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>Immune Response Against Toxoplasmosis&#x02010;Some Recent Updates RH: <italic toggle="yes">Toxoplasma gondii</italic> Immune Response</article-title>.&#x0201d; <source>International Journal of Immunopathology and Pharmacology</source>
<volume>36</volume>: <elocation-id>1190298532</elocation-id>.</mixed-citation></ref><ref id="mbt270143-bib-0034"><mixed-citation publication-type="journal" id="mbt270143-cit-0034">
<string-name>
<surname>Shen</surname>, <given-names>B.</given-names>
</string-name>, and <string-name>
<given-names>L. D.</given-names>
<surname>Sibley</surname>
</string-name>. <year>2014</year>. &#x0201c;<article-title>
<italic toggle="yes">Toxoplasma</italic> Aldolase Is Required for Metabolism but Dispensable for Host&#x02010;Cell Invasion</article-title>.&#x0201d; <source>Proceedings of the National Academy of Sciences of the United States of America</source>
<volume>111</volume>: <fpage>3567</fpage>&#x02013;<lpage>3572</lpage>.<pub-id pub-id-type="pmid">24550496</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0035"><mixed-citation publication-type="journal" id="mbt270143-cit-0035">
<string-name>
<surname>Shu</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Jin</surname>
</string-name>, <string-name>
<given-names>J. E.</given-names>
<surname>Rothman</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Zhang</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>Munc13&#x02010;1 MUN Domain and Munc18&#x02010;1 Cooperatively Chaperone SNARE Assembly Through a Tetrameric Complex</article-title>.&#x0201d; <source>Proceedings of the National Academy of Sciences of the United States of America</source>
<volume>117</volume>: <fpage>1036</fpage>&#x02013;<lpage>1041</lpage>.<pub-id pub-id-type="pmid">31888993</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0036"><mixed-citation publication-type="journal" id="mbt270143-cit-0036">
<string-name>
<surname>Stanley</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Buxton</surname>
</string-name>, <string-name>
<given-names>E. A.</given-names>
<surname>Innes</surname>
</string-name>, and <string-name>
<given-names>J. F.</given-names>
<surname>Huntley</surname>
</string-name>. <year>2004</year>. &#x0201c;<article-title>Intranasal Immunisation With <italic toggle="yes">Toxoplasma gondii</italic> Tachyzoite Antigen Encapsulated Into PLG Microspheres Induces Humoral and Cell&#x02010;Mediated Immunity in Sheep</article-title>.&#x0201d; <source>Vaccine</source>
<volume>22</volume>, no. <issue>29&#x02010;30</issue>: <fpage>3929</fpage>&#x02013;<lpage>3941</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2004.04.022</pub-id>.<pub-id pub-id-type="pmid">15364441</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0037"><mixed-citation publication-type="journal" id="mbt270143-cit-0037">
<string-name>
<surname>Su</surname>, <given-names>Y. J.</given-names>
</string-name>, <string-name>
<given-names>Z. D.</given-names>
<surname>Ma</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Qiao</surname>
</string-name>, et&#x000a0;al. <year>2022</year>. &#x0201c;<article-title>Geospatial Epidemiology of <italic toggle="yes">Toxoplasma gondii</italic> Infection in Livestock, Pets, and Humans in China, 1984&#x02013;2020</article-title>.&#x0201d; <source>Parasitology Research</source>
<volume>121</volume>, no. <issue>2</issue>: <fpage>743</fpage>&#x02013;<lpage>750</lpage>. <pub-id pub-id-type="doi">10.1007/s00436-021-07415-1</pub-id>.<pub-id pub-id-type="pmid">34988670</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0038"><mixed-citation publication-type="journal" id="mbt270143-cit-0038">
<string-name>
<surname>Suarez</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Lentini</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Ramaswamy</surname>
</string-name>, et&#x000a0;al. <year>2019</year>. &#x0201c;<article-title>A Lipid&#x02010;Binding Protein Mediates Rhoptry Discharge and Invasion in Plasmodium Falciparum and <italic toggle="yes">Toxoplasma gondii</italic> Parasites</article-title>.&#x0201d; <source>Nature Communications</source>
<volume>10</volume>, no. <issue>1</issue>: <fpage>4041</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-11979-z</pub-id>.</mixed-citation></ref><ref id="mbt270143-bib-0039"><mixed-citation publication-type="journal" id="mbt270143-cit-0039">
<string-name>
<surname>Sugi</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Tu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Ma</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Tomita</surname>
</string-name>, <string-name>
<given-names>L. M.</given-names>
<surname>Weiss</surname>
</string-name>, and <string-name>
<given-names>J. P.</given-names>
<surname>Boyle</surname>
</string-name>. <year>2017</year>. &#x0201c;<article-title>
<italic toggle="yes">Toxoplasma gondii</italic> Requires Glycogen Phosphorylase for Balancing Amylopectin Storage and for Efficient Production of Brain Cysts</article-title>.&#x0201d; <source>MBio</source>
<volume>8</volume>: <elocation-id>e01289&#x02010;17</elocation-id>.<pub-id pub-id-type="pmid">28851850</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0040"><mixed-citation publication-type="journal" id="mbt270143-cit-0040">
<string-name>
<surname>Tagoe</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>A. A.</given-names>
<surname>Drozda</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Falco</surname>
</string-name>, <string-name>
<given-names>T. J.</given-names>
<surname>Bechtel</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Weerapana</surname>
</string-name>, and <string-name>
<given-names>M. J.</given-names>
<surname>Gubbels</surname>
</string-name>. <year>2021</year>. &#x0201c;<article-title>Ferlins and TgDOC2 in Toxoplasma Microneme, Rhoptry and Dense Granule Secretion</article-title>.&#x0201d; <source>Life (Basel)</source>
<volume>11</volume>: <fpage>217</fpage>.<pub-id pub-id-type="pmid">33803212</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0041"><mixed-citation publication-type="journal" id="mbt270143-cit-0041">
<string-name>
<surname>Venugopal</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Chehade</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Werkmeister</surname>
</string-name>, et&#x000a0;al. <year>2020</year>. &#x0201c;<article-title>Rab11a Regulates Dense Granule Transport and Secretion During <italic toggle="yes">Toxoplasma gondii</italic> Invasion of Host Cells and Parasite Replication</article-title>.&#x0201d; <source>PLoS Pathogens</source>
<volume>16</volume>, no. <issue>5</issue>: <elocation-id>e1008106</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1008106</pub-id>.<pub-id pub-id-type="pmid">32463830</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0042"><mixed-citation publication-type="journal" id="mbt270143-cit-0042">
<string-name>
<surname>Verdaguer</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Corbalan&#x02010;Garcia</surname>
</string-name>, <string-name>
<given-names>W. F.</given-names>
<surname>Ochoa</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Fita</surname>
</string-name>, and <string-name>
<given-names>J. C.</given-names>
<surname>Gomez&#x02010;Fernandez</surname>
</string-name>. <year>1999</year>. &#x0201c;<article-title>Ca(2+) Bridges the C2 Membrane&#x02010;Binding Domain of Protein Kinase Calpha Directly to Phosphatidylserine</article-title>.&#x0201d; <source>EMBO Journal</source>
<volume>18</volume>: <fpage>6329</fpage>&#x02013;<lpage>6338</lpage>.<pub-id pub-id-type="pmid">10562545</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0043"><mixed-citation publication-type="journal" id="mbt270143-cit-0043">
<string-name>
<surname>Wang</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Tang</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Yang</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Fang</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>
<italic toggle="yes">Toxoplasma gondii</italic> ADSL Knockout Provides Excellent Immune Protection Against a Variety of Strains</article-title>.&#x0201d; <source>Vaccines (Basel)</source>
<volume>8</volume>, no. <issue>1</issue>: <elocation-id>16</elocation-id>. <pub-id pub-id-type="doi">10.3390/vaccines8010016</pub-id>.<pub-id pub-id-type="pmid">31935935</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0044"><mixed-citation publication-type="journal" id="mbt270143-cit-0044">
<string-name>
<surname>Wilson</surname>, <given-names>Z. N.</given-names>
</string-name>, <string-name>
<given-names>C. A.</given-names>
<surname>Gilroy</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Boitz</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Ullman</surname>
</string-name>, and <string-name>
<given-names>P. A.</given-names>
<surname>Yates</surname>
</string-name>. <year>2012</year>. &#x0201c;<article-title>Genetic Dissection of Pyrimidine Biosynthesis and Salvage in <italic toggle="yes">Leishmania donovani</italic>
</article-title>.&#x0201d; <source>Journal of Biological Chemistry</source>
<volume>287</volume>: <fpage>12759</fpage>&#x02013;<lpage>12770</lpage>.<pub-id pub-id-type="pmid">22367196</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0045"><mixed-citation publication-type="journal" id="mbt270143-cit-0045">
<string-name>
<surname>Xia</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Ye</surname>
</string-name>, et&#x000a0;al. <year>2018</year>. &#x0201c;<article-title>Functional Analysis of Toxoplasma Lactate Dehydrogenases Suggests Critical Roles of Lactate Fermentation for Parasite Growth In&#x000a0;Vivo</article-title>.&#x0201d; <source>Cellular Microbiology</source>
<volume>20</volume>: <elocation-id>e12794</elocation-id>. <pub-id pub-id-type="doi">10.1111/cmi.12794</pub-id>.</mixed-citation></ref><ref id="mbt270143-bib-0046"><mixed-citation publication-type="journal" id="mbt270143-cit-0046">
<string-name>
<surname>Xu</surname>, <given-names>G. Y.</given-names>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>McDonagh</surname>
</string-name>, <string-name>
<given-names>H. A.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>E. A.</given-names>
<surname>Nalefski</surname>
</string-name>, <string-name>
<given-names>J. D.</given-names>
<surname>Clark</surname>
</string-name>, and <string-name>
<given-names>D. A.</given-names>
<surname>Cumming</surname>
</string-name>. <year>1998</year>. &#x0201c;<article-title>Solution Structure and Membrane Interactions of the C2 Domain of Cytosolic Phospholipase a2</article-title>.&#x0201d; <source>Journal of Molecular Biology</source>
<volume>280</volume>: <fpage>485</fpage>&#x02013;<lpage>500</lpage>.<pub-id pub-id-type="pmid">9665851</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0047"><mixed-citation publication-type="journal" id="mbt270143-cit-0047">
<string-name>
<surname>Xu</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<given-names>N. Z.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Q. D.</given-names>
<surname>Tan</surname>
</string-name>, et&#x000a0;al. <year>2014</year>. &#x0201c;<article-title>Evaluation of Immuno&#x02010;Efficacy of a Novel DNA Vaccine Encoding <italic toggle="yes">Toxoplasma gondii</italic> Rhoptry Protein 38 (TgROP38) Against Chronic Toxoplasmosis in a Murine Model</article-title>.&#x0201d; <source>BMC Infectious Diseases</source>
<volume>14</volume>: <fpage>525</fpage>.<pub-id pub-id-type="pmid">25267356</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0048"><mixed-citation publication-type="journal" id="mbt270143-cit-0048">
<string-name>
<surname>Yang</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Qian</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Zhao</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Fang</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>
<italic toggle="yes">Toxoplasma gondii</italic> &#x003b1;&#x02010;Amylase Deletion Mutant Is a Promising Vaccine Against Acute and Chronic Toxoplasmosis</article-title>.&#x0201d; <source>Microbial Biotechnology</source>
<volume>13</volume>: <fpage>2057</fpage>&#x02013;<lpage>2069</lpage>.<pub-id pub-id-type="pmid">32959958</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0049"><mixed-citation publication-type="journal" id="mbt270143-cit-0049">
<string-name>
<surname>Yang</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Diao</surname>
</string-name>, et&#x000a0;al. <year>2017</year>. &#x0201c;<article-title>ANK1 and DnaK&#x02010;TPR, Two Tetratricopeptide Repeat&#x02010;Containing Proteins Primarily Expressed in <italic toggle="yes">Toxoplasma</italic> Bradyzoites, Do Not Contribute to Bradyzoite Differentiation</article-title>.&#x0201d; <source>Frontiers in Microbiology</source>
<volume>8</volume>: <fpage>2210</fpage>.<pub-id pub-id-type="pmid">29180989</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0050"><mixed-citation publication-type="journal" id="mbt270143-cit-0050">
<string-name>
<surname>Zhang</surname>, <given-names>D.</given-names>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Aravind</surname>
</string-name>. <year>2010</year>. &#x0201c;<article-title>Identification of Novel Families and Classification of the C2 Domain Superfamily Elucidate the Origin and Evolution of Membrane Targeting Activities in Eukaryotes</article-title>.&#x0201d; <source>Gene</source>
<volume>469</volume>: <fpage>18</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">20713135</pub-id>
</mixed-citation></ref><ref id="mbt270143-bib-0051"><mixed-citation publication-type="journal" id="mbt270143-cit-0051">
<string-name>
<surname>Zhang</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Li</surname>
</string-name>, et&#x000a0;al. <year>2020</year>. &#x0201c;<article-title>Identification of <italic toggle="yes">Toxoplasma gondii</italic> Tyrosine Hydroxylase (TH) Activity and Molecular Immunoprotection Against Toxoplasmosis</article-title>.&#x0201d; <source>Vaccines (Basel)</source>
<volume>8</volume>: <elocation-id>158</elocation-id>. <pub-id pub-id-type="doi">10.3390/vaccines8020158</pub-id>.<pub-id pub-id-type="pmid">32244791</pub-id>
</mixed-citation></ref></ref-list></back></article>